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INTRODUCTION: Coping with negative experience is essential for survival. Animals must quickly recognize a harmful situation, produce 
an adequate response, and learn its context, so that they can predict the reoccurrences of similar experiences. This process requires the lateral 
habenula (LHb) and the medial ventral tegmental area (mVTA) for evaluating and predicting aversive stimuli. LHb neurons promote encoding 
of aversive behavior, learn to respond to cues that predict aversive stimuli and activate negative experience-processing mVTA dopaminergic 
neurons (DA). Over-excitation of LHb neurons lead to depression-like symptoms, whereas their inactivation has an anti-depressant effect. 
Coping with negative experience also requires the septo-hippocampal system to record and recall contextual memories of events. This process 
necessitates increased firing of pacemaker parvalbumin (PV)-positive neurons in the medial septum and the vertical limbs of the diagonal 
bands of Broca (MS/VDB) and subsequent theta-oscillations in the hippocampus. However, how all these brain centers coordinate their 
activity during adverse events is poorly understood.  
 
RATIONALE: Because LHb does not project directly to the septo-hippocampal system, the brainstem median raphe region (MRR) has been 
proposed to coordinate their activity. Although MRR plays an important role in regulating mood, fear and anxiety and neuronal projections 
from it have been extensively studied for decades, yet it is still unclear how MRR neurons process these negative experiences. Using cell type-
specific neuronal tract-tracing, monosynaptic rabies-tracing, block-face scanning immuno-electron microscopy, in vivo and in vitro 
electrophysiological methods, we investigated the neurons of mouse MRR that are responsible for these functions. We used in vivo 
optogenetics combined with behavioral experiments or electrophysiological recordings to explore the role of MRR neurons responsible for 
the acquisition of negative experience. 
 
RESULTS: We discovered that the MRR harbors a vesicular glutamate transporter 2 (vGluT2)-positive cell population that gave rise to the 
largest ascending output of the MRR. These neurons received extensive inputs from negative sensory experience-related brain centers, whereas 
their excitatory fibers projected to LHb, mVTA and MS/VDB (Fig. A). MRR vGluT2-neurons mainly innervated MRR- or mVTA-projecting 
cells in medial (“limbic”) LHb, creating a direct feedback in the MRR-LHb-mVTA axis. MRR vGluT2-neurons were selectively activated by 
aversive but not rewarding stimuli in vivo. Stimulation of MRR vGluT2-neurons induced strong aversion (Fig. B-D), agitation and aggression 
and suppressed reward-seeking behavior, whereas their chronic activation induced depression-related anhedonia. The latter can at least partly 
be explained by our 3D electron microscopy data showing highly effective synaptic targeting of LHb neurons and by our in vitro data showing 
that MRR vGluT2-terminals can trigger depressive behavior-related bursting activity of LHb neurons. MRR vGluT2-neurons seem to be 
involved in active responses to negative experience, therefore they induced aggression or avoidance, classical fight or flight responses. 
Suppression of MRR vGluT2-neurons precisely at the moment of the aversive stimulus presentation strongly disrupted the expression of both 
contextual and cued fear memories and prevented fear generalization. MRR vGluT2-neurons could facilitate the learning of negative 
experience, because their LHb-projecting axons bifurcated and selectively innervated pacemaker MS/VDB PV-positive neurons that projected 
to the hippocampus. Consequently, in vivo stimulation of MRR vGluT2-neurons instantly evoked memory acquisition-promoting 
hippocampal theta-oscillations in mice, in vivo. 
 
CONCLUSION: Our results revealed that the MRR harbors a previously unrecognized brainstem center that serves as a key hub for the 
acquisition of negative experience. MRR vGluT2-neurons could activate the aversion- and negative prediction-related LHb-mVTA axis and 
could swiftly transform the state of the septo-hippocampal system for immediate acquisition of episodic memories of the negative experience. 
Maladaptations in processing negative experience is the basis of several types of mood disorders, which have a huge social and economic 
impact on individuals and society. Selective targeting of this neural hub may form the basis of new therapies. 
 
 
MRR vGluT2-neurons serve as a 
key hub for aversive behavior. MRR 
vGluT2 (VG2)-neurons process 
aversive events by activating neurons 
of LHb and mVTA, and hippocampus 
(HIPP)-projecting memory acquisition-
promoting parvalbumin (PV)-positive 
cells in MS/VDB (A). After viruses 
made MRR vGluT2-neurons light-
sensitive (B), mice were light-
stimulated in a specific area (C) that 
caused significant avoidance of that 
area, compared to control mice (D). 
(PFC: prefrontal cortex) 
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Abstract 
Adverse events need to be quickly evaluated and memorized, yet how these processes are coordinated 
is poorly understood. We discovered a large population of excitatory neurons in median raphe region (MRR) 
expressing vesicular glutamate transporter 2 (vGluT2) that received inputs from several negative experience-
related brain centers, projected to the main aversion centers and activated septo-hippocampal system pivotal 
for learning of adverse events. They were selectively activated by aversive but not rewarding stimuli. Their 
stimulation induced place aversion, aggression, depression-related anhedonia, suppression of reward-seeking 
behavior and memory acquisition-promoting hippocampal theta-oscillations. By contrast, their suppression 
impaired both contextual and cued fear memory-formation. These results suggest that MRR vGluT2-neurons 
are crucial for the acquisition of negative experiences and may play a central role in depression-related mood 
disorders. 
 
 
Introduction 
To survive, animals must quickly recognize a harmful situation, produce an adequate response, and 
learn its context to help predict the occurrence of similar negative experiences in the future (1–6). This process 
requires the lateral habenula (LHb) and medial ventral tegmental area (mVTA) for evaluating and predicting 
aversive stimuli, and requires the septo-hippocampal system to record and recall memories of these adverse 
events. Yet, how these brain centers coordinate their activity during adverse events is poorly understood. 
Because LHb does not project directly to the septo-hippocampal system, the brainstem median raphe region 
(MRR) has been proposed to coordinate their activity (7–14). Although the MRR plays an important role in 
regulating mood, fear and anxiety, its role in processing negative experience remains elusive (13, 15, 16). It 
contains projection neurons expressing serotonin (5HT) and/or type 3 vesicular glutamate transporter 
(vGluT3), yet after decades of studies, it is still unclear how MRR neurons can support these functions (17–19). 
Although projections from the MRR to LHb, mVTA, medial septum and the vertical limbs of the diagonal bands 
of Broca (MS/VDB) must be crucial to understand negative experience-related behavior, the identity of key 
MRR neurons responsible for these connections remains unknown (20, 21).  
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Results 
 
Most MRR projection neurons are vGluT2-positive  
In mice the transmitter phenotypes and targets of almost 25% of MRR neurons are unknown (22). 
Here, injections of the Cre-dependent tracer virus AAV5-eYFP (Supplementary Materials) into the MRR of 
vGluT2-Cre mice, together with complete stereological measurements revealed that at least 20% of the MRR 
neurons are vGluT2-positive (Fig. 1A-C, Table S5, see Supplementary Materials). MRR vGluT2-positive neurons 
were evenly distributed both in the median and the para-median part of the MRR. Fluorescent 
immunohistochemistry demonstrated that this group of cells was distinct from 5HT- and/or vGluT3-positive 
neurons in the MRR (Fig. 1B). Terminals of eYFP-expressing MRR neurons of vGluT2-Cre mice were positive for 
vGluT2 (Fig. S1A-B), but they do not express the plasma membrane serotonin transporter (SERT), vesicular 
GABA transporter (vGAT) or vGluT3 (Fig. S1C).  
 
MRR vGluT2-neurons are linked to negative experience-related brain regions 
 Viral labeling of vGluT2-neurons with Cre-dependent AAV5-eYFP in vGluT2-Cre mice revealed that they 
strongly innervate the LHb and the mVTA (Fig. 1E-F), as well as other neurons locally (Fig. S1D). We never 
observed similar innervation patterns after injecting surrounding brain areas in vGluT2-Cre mice, nor after 
injecting AAV5-eYFP into the MRR of TpH-Cre, vGluT3-Cre or vGAT-Cre mice (labeling serotonergic, vGluT3-
positive and GABAergic MRR neurons respectively, Fig. S3A-I). 
Injections of Cre-dependent AAV5-eYFP into the MRR of vGluT2-Cre mice showed that MRR vGluT2-
neuronal projections avoided positive reinforcement-related lateral VTA DA cells (Fig. 1G). Instead, they 
innervated mVTA DA neurons (Fig. 1G-H). Glutamatergic LHb neurons also innervate mVTA DA cells to regulate 
negative reward predictions and aversive behavior (1–3, 23). Indeed, when we simultaneously injected AAV5-
mCherry into the LHb and AAV5-eYFP into the MRR of the same vGluT2-Cre mice, we detected that both LHb 
and MRR vGluT2-neurons targeted the mVTA specifically (Fig. 1G-H).  
 Aversion-related mVTA DA cells target the medial prefrontal cortex (mPFC) (23, 24). We injected the 
retrograde tracer Choleratoxin B subunit (CTB) into the mPFC and Cre-dependent AAV5-eYFP into the MRR of 
vGluT2-Cre mice (Fig. S1E). vGluT2-positive MRR terminals established synaptic contacts with those mVTA DA 
neurons that project to the mPFC (Fig. S1F-G), showing that vGluT2-positive MRR neurons target DA cells 
related to negative reward predictions.  
Glutamatergic LHb neurons (primarily in the medial part of LHb) also innervate the MRR (25), but the 
identity of their target cells is unknown. We injected Cre-dependent AAV5-eYFP into the MRR and AAV5-
mCherry into the LHb of vGluT2-Cre mice and found that MRR vGluT2 neurons primarily targeted the medial 
part of LHb (Fig. 1E), whereas at least 39% of LHb terminals innervated vGluT2-positive neurons in the MRR 
(Fig. 1I-L). Serotonergic and vGluT3-positive MRR neurons were also targeted by LHb vGluT2 neurons (for the 
exact ratios see Fig. S2F-G). Using combined anterograde and retrograde tracing, we also found that there is a 
direct reciprocal connection between the LHb-projecting vGluT2-positive MRR neurons and the MRR-
projecting vGluT2-positive LHb neurons (Fig. 1I, for measured ratios see Fig. S1H-J, Fig. S2A-E, Supplementary 
Materials). vGluT2-positive MRR neurons also innervate LHb neurons that project to the mVTA (Fig. S1H-J). 
These results indicate an excitatory positive feed-back loop between the vGluT2-neurons of MRR and LHb. 
Both of these neuronal populations project to the aversion-encoding mVTA as well. 
To identify upstream brain areas that synaptically target the MRR vGluT2-positive neurons, we used 
mono-trans-synaptic rabies tracing (26). We used a Cre-dependent helper virus encoding both an avian tumor 
virus receptor A (TVA) and an optimized rabies glycoprotein, and we used a TVA-receptor-dependent and 
glycoprotein-deleted rabies virus in vGluT2-Cre mice (Supplementary Materials, Fig. 1N-O), the specificity of 
which virus combination has already been validated in our previous study (27). Brain areas that play an 
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essential role in negative experience-related behavior showed a strong convergence onto vGluT2-positive MRR 
cells, including the dorsal raphe, lateral hypothalamus, periaqueductal grey or zona incerta (Fig. 1P-T, for 
details see Table S6). LHb accounts for most of the monosynaptically labelled input cells (Fig. 1R). Areas related 
to the encoding of aversive memories (like the mammillary areas, the pontine reticular nucleus or nucleus 
incertus) also sent strong projections onto vGluT2-positive MRR neurons (Table S6).  
 
MRR vGluT2-neurons establish multiple burst-promoting synapses on LHb neurons  
 Negative experience-related behavior and subsequent depression-like symptoms are strongly 
promoted by the excitatory inputs of LHb neurons (28–30). Using block-face scanning electron microscopy, we 
revealed that MRR vGluT2-neurons provide an extensive synaptic coverage on LHb neurons (Fig. 2A-B, E-F) and 
most of its axon terminals established more than one synapse on different or the same target cells (Fig. 2D). 
N-methyl-D-aspartate (NMDA)-receptor-dependent burst-firing in LHb neurons play a key role in the 
development of depression (28, 30). We found that MRR vGluT2-neurons established NMDA receptor-
containing excitatory glutamatergic synapses on LHb neurons (Fig. 2C). In LHb, astroglia cooperate with 
excitation to regulate neuronal bursting and depression-like symptoms (28). These glial processes enwrapped 
most synapses of MRR vGluT2-terminals in LHb (Fig. 2B, E, F).  
 To test this physiologically, we selectively activated MRR vGluT2-fibers in the LHb in vitro, using 
channelrhodopsin 2 (ChR2)-containing Cre-dependent AAV5-ChR2-eYFP in optogenetic experiments (Fig. 3A). 
Light stimulation of ChR2-containing MRR vGluT2-positive fibers reliably evoked glutamatergic excitatory 
postsynaptic currents (EPSCs) in voltage-clamped neurons of LHb (Fig. 3B, Fig.S4A-B), which received MRR 
vGluT2-terminals (Fig. 3G). These EPSCs showed strong short-term depression and they were abolished by the 
simultaneous blockade of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)- and NMDA-type 
glutamate receptors (Fig. 3B-D). After activating ChR2-expressing vGluT2-positive MRR terminals in the LHb, 
we frequently observed the induction of burst-firing in LHb neurons (Fig. 3E-F), whereas some spontaneous 
burst-firing was also present in these neurons. Bursting disappeared after the combined blockade of AMPA- 
and NMDA-type glutamate receptors (Fig. 3E).  
 
MRR vGluT2-neurons are selectively activated by aversive stimuli in vivo 
 We explored the in vivo response of identified MRR vGluT2-neurons to aversive and rewarding stimuli. 
We used a combination of multichannel recording and optogenetic tagging in the MRR of Cre-dependent, AAV-
ChR2-eYFP injected vGluT2-Cre mice. Awake mice were head-fixed on top of an air-supported spherical 
treadmill, while multiple single units were simultaneously recorded from the MRR using a multichannel silicone 
probe. Light pulses that were used to tag vGluT2-neurons, were delivered through an optic fiber positioned 
above the MRR (Fig. 4A-B). Tagged neurons reliably responded to brief blue laser light pulses with short latency 
and small jitter (Fig. 4C). A large set of optogenetically identified vGluT2-positive MRR neurons were robustly 
activated by strongly aversive air puffs (Fig. 4D-F). By contrast, MRR vGluT2-neurons were practically never 
affected by rewarding stimuli (water drops, Fig. 4D-F). Mildly aversive LED flashes triggered a slight, transient 
elevation of activity in a small subgroup of vGluT2-positive MRR neurons, partially overlapping with the air-
puff activated group (Fig. S4G-H), but this effect was significantly lower compared to air-puff (Fig. 4D-F).  
 
Optogenetic activation of MRR vGluT2-neurons causes strongly aversive behavior 
 The rapid, adverse experience-specific in vivo activity of MRR vGluT2-neurons suggest that they 
specifically process negative experience. To light-activate MRR vGluT2-neurons selectively in vivo, we injected 
ChR2-containing Cre-dependent AAV5-ChR2-eYFP into the MRR of vGluT2-Cre mice (“ChR2-mice”). Control 
mice were injected with a control virus that expressed no ChR2 (“CTRL-mice”). Then, we implanted an optic 
fiber over the MRR (Supplementary Materials, Fig. 5A, Fig. S5). After handling, mice were placed into a chamber 
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containing two different areas with different visual cues (Fig. 5A). In the habituation session, mice did not 
prefer any of the two areas (Fig. S6A-B). 24 hours later, mice were placed into the same chamber and received 
optogenetic stimulation (25Hz) only in one area of the chamber (area selection was systematically random). 
ChR2-mice, but not CTRL-mice, showed a powerful and immediate real-time place aversion of the stimulation-
linked area (Fig. 5A-B, Fig. S6A-B). On the next day, previously stimulated ChR2-mice, but not CTRL-mice, 
showed a strong conditioned aversion of the area that was previously linked to stimulation (Fig. 5A-B, Fig. S6A-
B).  
 We investigated whether the activity of MRR vGluT2-neurons is powerful enough to counteract the 
strongly positive expectation of a motivated, food-seeking animal. Here, the above mentioned ChR2- and CTRL-
mice were food-restricted, and were trained for 10 days in an operant conditioning task to nose-poke for food 
rewards (Fig. 5C, Supplementary Materials). On the last day of their training, both groups of mice reached a 
plateau in the total number of nose-pokes during the 30 minutes-long operant conditioning session (Fig. 5C). 
24 hours later, mice received blue laser stimulation that started after each rewarded nose-poke during the 
whole, 30 minutes-long session. ChR2-mice, but not CTRL-mice, poked significantly less for reward pellets, 
compared to the last day of their training (Fig. 5D-E).  
We also tested whether the activation of these cells can induce passive coping. We performed an 
optogenetic contextual fear conditioning experiment with the same cohort of mice that participated in the 
operant conditioning task (Fig. S6C). Mice were allowed 3 days to rest and regain their original weight, and on 
the 25th day, they were put into a new environment, where they received 15 seconds-long laser stimulation 
ten times. 24 hours later, mice were tested in the same environment. Neither ChR2-mice, nor CTRL-mice 
showed any sign of freezing behavior, neither during light stimulation nor 24 hours later in the same 
environment (Fig. S6C).  
 
Activation of MRR vGluT2-neurons induces aggression and depressive symptoms 
 Neuronal activity in LHb is related to aggressive behavior (31). Therefore, we investigated whether 
activation of MRR vGluT2-neurons induces the prediction of negative experience in a social context and 
whether it promotes an aggressive behavior in mice during these social interactions. We used a DREADD 
(Designer Receptors Exclusively Activated by Designer Drugs)-containing AAV based chemogenetic tool that 
expresses mutant receptors that activates cells upon binding to clozapine-N-oxide (CNO). We injected either 
Cre-dependent excitatory DREADD virus AAV8-h3MDq-mCherry (“hM3Dq-mice”) or Cre-dependent AAV8-
mCherry virus (“CTRL-mice”) into the MRR of vGluT2-Cre mice. Then, both hM3Dq- and CTRL-mice received 
intraperitoneal injections of CNO (Fig. 6A, see Supplementary Materials) and performed two behavioral tests. 
In the social interaction test, mice were placed into a new environment 30 minutes after CNO injections, 
together with an unfamiliar mouse. CTRL-mice showed mostly prosocial behavior towards the conspecific (Fig. 
6B). In contrast, hM3Dq-mice became highly aggressive (Fig. 6B, Fig. S4C-F). Five days later, we carried out a 
resident-intruder test. Thirty minutes after CNO injections, a subordinate intruder mouse was placed into the 
home cage of the CTRL- or hM3Dq-mice. Again, hM3Dq-mice became highly aggressive towards the intruder 
(Fig. 6C, Fig. S4C-F). In a separate experiment, chemogenetic activation of AAV8-h3MDq-expressing MRR 
vGluT2-neurons by CNO injections also induced significantly higher motor activities in a Y-maze compared to 
CTRL-mice (Fig. S4I).  
Aggressive behavior frequently accompanies depressive state (32–34), which is also promoted by 
chronic over-activation and burst-firing of LHb neurons (28–31, 35). Using the above mentioned types of CTRL- 
and hM3Dq-mice, we tested whether chronic activation of MRR vGluT2-neurons promoted depression-like 
symptoms. Mice received intraperitoneal injections of the DREADD-agonist CNO three times a week, for three 
weeks (Fig. 6A, Supplementary Materials). On day 19, mice were tested in a sucrose preference test, which can 
detect anhedonia, a classic symptom of depression (36). CTRL-mice preferred the 1% sucrose solution over 
6 
 
water significantly more than hM3Dq-mice (Fig. 6D). The postmortem weight of the adrenal glands of hM3Dq-
mice was significantly higher than that for CTRL-mice (Fig. S4J). 
  
MRR vGluT2-neurons activate memory acquisition-promoting MS/VDB neurons 
 Fast and effective processing of negative experience requires the immediate induction of memory 
acquisition, which necessitates a rapid change in the state of the MS/VDB-hippocampal system (37). Indeed, 
after AAV5-eYFP labeling of MRR vGluT2-neurons, we observed an abundant axonal labeling in the MS/VDB 
(Fig. 7A-B). MRR vGluT2-neurons established NMDA receptor-containing excitatory synapses selectively with 
PV-positive GABAergic cells in the MS/VDB (Fig. 7A-E, Supplementary Data for Figure 7, Fig. S1K). Using 
hippocampal injections of the retrograde tracer FluoroGold, in combination with AAV5-mCherry into the MRR 
of vGluT2-Cre mice we found that MRR vGluT2-neurons directly innervate hippocampus-projecting PV-neurons 
in MS/VDB (Fig 7F-H). These PV-neurons are the pacemakers of memory acquisition-promoting hippocampal 
theta-rhythm (38, 39).  
 The theta-rhythmic activity of LHb neurons and the hippocampal network are phase-locked and their 
concerted activity is necessary for proper memory formation (8, 14). Therefore, we investigated whether 
individual axons of MRR vGluT2-neurons bifurcate and target both areas. We performed double retrograde 
tracing by injecting CTB into the LHb and FluoroGold into the MS/VDB of vGluT2-Cre mice, and we labelled 
vGluT2-positive MRR cells with AAV5-mCherry (Fig. 7I-J).  
At least 61% of vGluT2 MRR neurons retrogradely labeled from MS/VDB were retrogradely labeled from LHb 
as well (Fig. 7K). 
 We also investigated the effect of activation of MRR vGluT2-neurons on hippocampal network activity 
in vivo. Using AAV5-ChR2-eYFP, we expressed ChR2 in MRR vGluT2-neurons and implanted an optic fiber over 
the MRR and a Buzsaki-probe into the dorsal CA1 (Fig. 8A). Ten-second-long stimulation of MRR vGluT2-
neurons by a 25 Hz light-train triggered some movement (possibly related to the above-mentioned active 
avoidance of the stimuli) and they triggered hippocampal theta-oscillations (Fig. 8B-D) known to facilitate the 
formation of memories. 
 
MRR vGluT2-neurons are necessary for fear memory acquisition 
MRR vGluT2-neurons are specifically excited by negative experience, which they relay to aversion 
centers and to the septo-hippocampal system, likely promoting memory encoding. We injected Cre-dependent 
Archaerhodopsin T-3 (ArchT 3.0)-containing AAV5-ArchT-GFP (ArchT-mice) or control Cre-dependent AAV5-
eYFP (CTRL-mice) into the MRR of vGluT2-Cre mice, and implanted an optic fiber over the MRR (Fig. 8E, Fig. 
S5). After handling, mice were tested in a delay cued fear conditioning paradigm. First, we placed mice into a 
new environment “A”, where they received three auditory tones, at the end of which they received foot-shocks 
and light illuminations. Light delivery was precisely aligned to foot-shocks (Fig. 8E). All mice displayed equally 
strong immediate reactions to foot-shocks. In the following tests, mice received no more light illumination. 24 
hours later, mice were placed into the same environment “A” to test their contextual memories. CTRL-mice 
expressed strong contextual freezing behavior, whereas ArchT-mice showed almost no freezing behavior (Fig. 
8E). On the next day, we placed mice into a different, neutral environment (environment “B”), where ArchT-
mice showed significantly lower generalized fear compared to CTRL-mice (Fig. 8E). Then, in the same neutral 
environment, we presented the mice with the auditory cue. CTRL-mice showed very high levels of freezing. In 
contrast, light inhibited ArchT-mice showed significantly diminished freezing, indicating impaired fear memory 
formation (Fig. 8E). Even after cue presentation was over, the difference between the fear levels of ArchT- and 
CTRL-mice remained significant (Fig. S6D).  
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Discussion 
Animals must recognize adverse events quickly, decide whether to fight or flight and in parallel they 
must efficiently learn the context of that event so that they can predict it in the future. The LHb and mVTA are 
activated during the acquisition of negative experience (7, 23, 24, 40), which initiates the encoding of “negative 
reward prediction errors” and aversion in these nuclei (5, 41). Activation of mVTA dopaminergic neurons is 
also aversive (23, 42), whereas the activity of lateral VTA neurons play a role in positive reinforcement. LHb 
contains nearly exclusively glutamatergic neurons, which encode aversive behavior and activate dopaminergic 
(DA) neurons of mVTA (23–25, 43). LHb activity also indirectly inhibits encoding of positive reinforcement in 
the lateral VTA (23, 44). These processes fine-tune future strategies in similar situations (5, 41, 45–48). LHb 
and mVTA conveys information related to negative predictions and learns to respond to cues that predict 
aversive stimuli (3, 42, 49–53).  
Meanwhile, the MS/VDB-hippocampal system must also be switched into the state optimal for 
memory acquisition to record the context of such events (8, 14). These processes are also necessary for the 
prediction and prevention of negative experience in the future. Yet, it was not clear which neuronal pathway 
orchestrates the coordinated activation of these networks. Although the MRR was known to play a central role 
in processing negative experience (15, 54), its known cell types did not project to the LHb, and the transmitter 
phenotypes and targets of almost 25% of the MRR neurons were not even known (22).  
We discovered that these previously unrecognized vGluT2-positive MRR neurons project heavily into 
the LHb, mVTA and MS/VDB (Fig. S7). They are the largest population of projection neurons from the MRR, 
they are glutamatergic and do not express 5HT, vGluT3 or vGAT. We detected an extensive convergence of 
monosynaptic inputs to MRR vGluT2-neurons from several environmental experience-related brain centers 
[Fig. S7, (7, 40, 55)]. MRR vGluT2-neurons predominantly innervate the medial (“limbic”) division of LHb that 
projects to the MRR and mVTA, but they mostly avoid lateral (“pallidal”) division of LHb that receives a different 
set of inputs (25, 51, 56, 57). MRR vGluT2-neurons directly innervate MRR- or mVTA-projecting LHb cells, 
creating a direct feedback in the MRR-LHb-mVTA axis.  
Our in vivo physiological measurements confirmed the central and specific role of MRR vGluT2-
neurons in the formation of negative experience. MRR vGluT2-neurons were strongly and specifically activated 
by strong aversive stimuli, they were mildly activated by weak aversive stimuli, whereas rewarding stimuli did 
not affect their activity. This suggests that these neurons are primarily responsible and necessary for relaying 
negative experience in the brainstem. Indeed, specific optogenetic inhibition of these neurons precisely during 
the presentation of adverse stimuli eliminated or significantly decreased hippocampus-dependent contextual 
or hippocampus-independent cued fear memories, respectively. These data showed that this neural hub is 
essential for processing negative experience. 
The elevation of excitatory transmission in the LHb or the stimulation of mVTA has similar effects (23, 
46, 58, 59). MRR vGluT2-neurons heavily project to LHb and also selectively innervate mVTA DA neurons (but 
do not innervate neurons in lateral VTA that are mostly reward-related), suggesting that they can effectively 
activate negative prediction centers. Indeed, their optogenetic activation triggered immediate behavioral 
changes by inducing acute place aversion. The adverse event was effectively memorized, because it induced 
conditioned place aversion. Furthermore, the selective activation of MRR vGluT2-neurons could negate an 
otherwise strongly rewarding behavior in an operant conditioning task. The activation of MRR vGluT2-neurons 
did not induce passive freezing behavior directly, instead MRR vGluT2-neurons seem to be involved in active 
responses to negative experience, and therefore they induce avoidance, flight or fight behavior.  
Depression is thought to be a result of a learning mechanism based on chronically sustained negative 
experiences (60, 61). Glutamatergic synapses on LHb neurons show long-term plasticity mechanisms, and LHb 
neurons can learn to respond to cues preceding aversive events (28, 29, 50, 62). The chronic elevation of 
glutamatergic transmission in LHb causes depressive disorder through the promotion of burst-firing of LHb 
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neurons, which is also regulated by adjacent glial cell coverage (28–30, 50, 63, 64). MRR vGluT2-neurons 
massively innervate LHb neurons with different types of NMDA receptor-containing excitatory contacts that 
are mostly covered by glial processes on LHb neurons. They can also evoke burst-firing of LHb neurons. We 
also revealed an abundant reciprocal excitatory connection between vGluT2-positive glutamatergic neurons 
of LHb and MRR that may result in a reverberation and may support pathological learning and excessive 
activation of LHb neurons, if the loop is not controlled effectively. To mimic a chronically maladapted circuitry, 
we chemogenetically induced chronic over-activation of vGluT2-positive MRR neurons and it caused 
anhedonia in the sucrose-preference test that is a typical sign of depressive disorder in mice.  
Aggression is a well-known symptom of depression in both mice and humans (32–34) and both LHb 
and MS/VDB plays a role in the emotional processing of aggressive behavior (31). Indeed, the activation of 
MRR vGluT2-neurons also promoted aggressive behavior. Aggression is commonly associated with agitation, 
the most distinguishing features of which include restlessness, pacing and motor activities. Indeed, we 
observed elevated locomotor activity and exploration in chemogenetically stimulated mice, which together 
suggests that activation of vGluT2-positive MRR neurons promotes agitation and active aversive behaviors 
(flight and/or fight responses) in neutral or social situations.  
MRR has a complex effect on the MS/VDB-hippocampal activity and the formation of contextual fear 
memories, although its mechanism is not well understood (9, 11). In vivo optogenetic activation of MRR 
promoted memory acquisition-related theta rhythm through a mechanism conveyed by a non-serotonergic 
and non-GABAergic MRR cell population (13). Activation of pacemaker PV-positive MS/VDB neurons are 
essential for the generation of hippocampal theta rhythm and proper episodic memory formation (38, 39, 65). 
PV-positive MS/VDB neurons are innervated by glutamatergic cells of the MRR (18, 66, 67), but the identity of 
those neurons were unknown. We discovered that MRR vGluT2-neurons not only project to the LHb/mVTA 
aversion axis, but the axons of most of these MRR vGluT2-positive excitatory neurons bifurcate and 
simultaneously innervate PV-positive neurons in the MS/VDB and can instantly and reliably promote 
hippocampal theta rhythm generation necessary for memory acquisition. MRR vGluT2-neurons increased 
theta rhythm-related exploratory behavior, while animals exhibited conditioned place aversion on the day 
following stimulation, suggesting the facilitation of strong memory formation. MRR vGluT2-neurons may also 
facilitate the phase-locking of theta rhythm in the LHb and the hippocampus.  
Our data revealed that the MRR vGluT2-positive neuronal population is a previously unrecognized 
neural hub of the brain that is both necessary and sufficient for the acquisition of negative experience, but 
which is not activated by positive rewarding experience. MRR vGluT2-neurons receive extensive convergence 
of inputs from sensory experience-related brain areas, its inhibition disrupts aversive memory formation, its 
activation promotes agitated and aversive behavior and flight, and it quickly negates motivated behavior. If 
flight is not an option during social interaction, it provokes fight and aggression. It also facilitates long-term 
memory formation related to negative experience and its chronic activation produces a depression-like 
phenotype, likely through inducing long-term bursting activity in LHb neurons (28, 30), which we showed in 
our vitro experiments. Therefore, vGluT2-positive MRR neurons control the acquisition of negative experience 
by simultaneously triggering the activity of brain aversion centers and hippocampal episodic memory 
encoding. Maladaptations in processing negative experience is the basis of several types of mood disorders, 
which have a huge social and economic impact on individuals and society. Selective targeting of this neural 
hub may form the basis of new therapies. 
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Fig. 1: vGluT2-neurons are the largest population of projection cells in MRR 
 
 
A: AAV5-eYFP labeling in MRR in vGluT2-Cre mice. Scale bar: 200 μm. 
B: eYFP-labelled vGluT2-positive (green arrows), immunolabelled TpH (serotonin)-positive (white arrows), 
vGluT3-positive (red arrows) and TpH/vGluT3 double positive (yellow arrow) cells in MRR. Scale bar: 20 μm.  
C: At least 20% of the MRR neurons are vGluT2-positive. (For stereological statistical details see Table S5). 
D: AAV2/5-EF1α-DIO-eYFP was injected into the MRR of vGluT2-Cre mice (n=3). 
E-F: Virally labelled vGluT2-positive MRR fibers innervate the LHb (primarily the medial part) and mVTA. 
Abbreviations: fr: fasciculus retroflexus; LHb-L: lateral habenula, lateral division; LHb-M: lateral habenula, 
medial division; MHb: medial habenula; VTA: ventral tegmental area. Scale bars: 200 μm. 
G: vGluT2-positive fibers from MRR (green) and LHb (red) innervate the same medial VTA, but not the lateral 
VTA. Dopaminergic cells were labelled with anti-tyrosine hydroxylase (TH, blue). Scale bar: 50 μm. (For 
statistical details see Suppl. Data for Fig. 1). 
H: vGluT2-positive MRR axon terminal (green) and an LHb terminal (red) establish Homer-1 (white) positive 
synaptic contacts with the same dopaminergic cell (TH, blue) in mVTA. Scale bar: 5 μm 
I: AAV2/5-EF1α-DIO-eYFP was injected into the MRR and AAV2/5-EF1α-DIO-mCherry was injected into the LHb 
of vGluT2-Cre mice, bilaterally (n=2). 
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J-K: Injection site in the LHb (J) and its vGluT2-positive fibers in the MRR (K). Scale bar: 200 µm.  
L: vGluT2-positive LHb fibers (red) establish Homer-1 (white) positive synaptic contacts (white arrowheads) 
with vGluT2-positive MRR neurons (green). Scale bar: 10 μm. (For statistical details see Suppl. Data for Fig. 1). 
M: vGluT2-positive MRR fibers (green) establish Homer-1 (white) positive synaptic contacts (white 
arrowheads) with vGluT2-positive LHb neurons (red). Scale bar: 5 µm.  
N: A helper AAV2/8-hSyn-FLEX-TpEp(oG) was injected into the MRR of vGluT2-Cre mice, followed by an 
injection of Rabies ΔG(EnvA)-mCherry two weeks later (n=3 mice).  
O: Injection site of helper (green) and rabies (red) viruses into the MRR of vGluT2-Cre mice. Inset illustrates 
some starter neurons expressing both viruses. Scale bar for large image is 100 µm, for inset it is 10 µm. 
P-T: Rabies labeled neurons in different brain areas establish synapses on vGluT2-positive MRR neurons. Scale 
bar for all images: 100 µm. (For abbreviations see Suppl. Data for Fig. 1, for detailed analysis see Table S6)  
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Fig. 2: MRR vGluT2-neurons establish glia-enwrapped glutamatergic synapses on LHb neurons  
 
 
 
A: AAV2/5-EF1a-DIO-eYFP was injected into the MRR of vGluT2-Cre mice. 
B: Scanning electron micrographs represent different types of synaptic contacts established by eYFP-positive 
MRR terminals (immunogold labeling, black spheres) on different subcellular compartments of LHb neurons. 
Arrows show synaptic edges. Abbreviations: D: dendrite, DS: dendritic spine, N: nucleus, S: soma, SS: somatic 
spine. Scale bar: 500nm. 
C:  AAV-eYFP positive terminals (serial sections of immunoperoxidase labeling, dark DAB precipitate) establish 
synapses on LHb neurons that contain the GluN2A (upper two images) or GluN1 (lower two images) NMDA-
receptor subunits (immunogold particles indicated with arrowheads). For statistical details, see Supplementary 
Data for Figure 2C.  Scale bar: 300 nm. 
D: MRR vGluT2-terminals establish more than one synapse on LHb neurons (from 2 mice). 
E: 3D reconstruction of MRR vGluT2 fibers (green) shows their synapses with different membrane domains of 
LHb neurons. Inset shows the abundant glial coverage around MRR vGluT2 terminals (blue).  
F: Schematic illustration of the proportion of MRR vGluT2 synapses on different membrane domains LHb 
neurons (from 2 mice). 
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Fig. 3: Fibers of MRR vGluT2-neurons evoke burst firing in LHb neurons 
 
 
A: AAV2/5-EF1α-DIO-ChR2-eYFP was injected into the MRR of vGluT2-Cre mice (n=3). Six weeks later, 300-μm-
thick horizontal in vitro slices were prepared from the LHb. Neurons in LHb were whole-cell patch clamped in 
voltage clamp mode. (Supplementary Methods and Suppl. Data for Fig. 3). 
B: Light stimulations of MRR vGluT2-fibers evoked excitatory postsynaptic currents (EPSCs) in LHb neurons. 
The average responses to 2ms light pulses are shown above individual grey traces. Responses are strong in 
control conditions (black), they were completely abolished (red trace) by 20 µM NBQX (AMPA/kainite receptor 
antagonists) and 50 µM AP5 (NMDA antagonist), and partially recovered after washout (teal).  Scale bars: 200 
ms, 200 pA. 
C: Cells displayed short-term depression of EPSC amplitudes at all stimulation frequencies (averages from 10 
cells, for statistical data see Suppl. Data for Fig. 3). 
D: EPSC amplitude and latency distributions from all 11 recorded neurons (in grey). EPSPs were sensitive for 
glutamatergic antagonists in 7 out of 7 tested cells (red), and partially recovered after washout (teal). (For 
statistical data see Suppl. Data for Fig. 3). 
E: Traces show representative current-clamped (I=0) LHb neurons displaying spontaneous (asterisks) and light-
evoked (pale blue lines, 5 pulses at 20 Hz) bursts. 10 consecutive stimulations are shown. Both spontaneous 
and light-evoked bursts were abolished by application of NBQX and AP5 (right panel). Scale bars: 1 sec, 20 mV. 
F: Peri-stimulus time-histogram show action potential distributions upon light stimuli (n=4 cells). 
G: A representative, recorded LHb cell (biocytin labeling, red) receives Homer-1 positive (white) synaptic 
contacts (white arrowheads) from eYFP-positive MRR fibers (green). Scale bar: 5 μm. 
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Fig. 4: In vivo, MRR vGluT2-neurons selectively respond to aversive stimuli  
 
  
 
A: AAV2/5-EF1a-DIO-ChR2-eYFP was injected into the MRR of vGluT2-Cre mice. A silicone probe was inserted 
into and an optical fiber was placed above the MRR. Mice were head-fixed on top of an air supported spherical 
treadmill, and strongly aversive (air puff), mildly aversive (LED flash) and rewarding (water drops) stimuli were 
randomly presented to the awake animals (8 mice). 
B: A representative image of virus expression (green) and the position of the implanted optic fiber (blue) and 
silicone probe (red DiI labeling) in the MRR of a vGluT2-Cre mouse. Scale bar: 200 µm. 
C: A raster plot and a peri-stimulus time histogram, corresponding to an optogenetically tagged vGluT2 neuron 
in the MRR, shows short latency, high success rate and low jitter of the responses. The blue square indicates 
the light pulse. 
D: A representative MRR vGluT2-neuron was robustly activated by an aversive air puff, was only weakly 
activated by a slightly aversive LED stimulus (LED) and showed no response to water reward. 
E: Top matrices show the reaction of individual MRR vGluT2-neurons to different stimuli (each row is one 
neuron’s z-scored peri-stimulus time histogram), sorted by descending response magnitudes. Bottom plots 
show average response across all tagged units (from 8 animals, mean +/- SEM).  
F: Paired plots of cells (same as displayed in E) show the baseline vs. stimulus-evoked firing activity of MRR 
vGluT2-neurons (grey: individual tagged neurons, black: mean +/- SEM). Air puffs evoked significantly larger 
response than LED flashes. Reward induced no significant population response. (For statistical data see Suppl. 
Data for Fig. 4). 
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Fig. 5: MRR vGluT2-neurons induce active avoidance of negative experience  
 
 
 
A: After injecting ChR2-containing AAV2/5-EF1a-DIO-ChR2-eYFP (“ChR2-mice”) or control (only eYFP 
containing) Cre-dependent AAV5 (“CTRL-mice”) into the MRR of vGluT2-Cre mice, we implanted an optic fiber 
over the MRR. Image represents an injection site in MRR and the position of the optic fiber (blue, scale bar: 
500 μm). Four weeks later, mice were habituated to a chamber with two areas. On day 7, mice received 25Hz 
light illumination in one of the areas of the chamber. ChR2 expressing mice showed significant real-time place 
aversion (RTPA) of the stimulated area, immediately. On day 8, no light was presented, but ChR2-mice 
displayed a significant conditioned place aversion (CPA), suggesting that the activity of MRR vGluT2-neurons 
can directly induce real-time and learned active contextual avoidance. (Also see Suppl. Fig. 6A) 
B: RTPA and CPA tests show significant effects (medians & interquartile ranges, for statistical details see Suppl. 
Data for Fig. 5). 
C: Between days 9-21 mice were food-restricted and learned to nose-poke for reward pellets (see 
Supplementary Methods for details). On day 22, mice received 5 second 25Hz light starting with the nose-
pokes. Compared to base performance (on day 21), ChR2-mice performed significantly less nose-pokes when 
nose-pokes were paired with laser stimulation (on day 22).  
D: The total number of nose-pokes for rewards during the base and stimulation performance in the operant 
conditioning task (For statistical details see Suppl. Data for Fig. 5). 
E: Nose-poke ratios of stimulation/base performance in the operant conditioning task (mean & SD, For 
statistical details see Suppl. Data for Fig. 5).  
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Fig. 6: Chronic over-activation of MRR vGluT2-neurons induces aggression and anhedonia  
 
 
  
A: AAV2/8-hSyn-DIO-hM3D(Gq)-mCherry or control AAV2/8-hSyn-DIO-mCherry was injected into the MRR of 
vGluT2-Cre mice (14 CTRL-and 8 hM3Dq-mice). All mice received hM3Dq-agonist clozapine N-oxide (CNO, 
1mg/10ml/kg intraperitoneally 30 min prior testing). Image represents a DAB labeled injection site in MRR 
(scale bar: 500 μm).  
B-C: Social interaction (B) and resident-intruder (C) tests. Percentage of time spent with aggressive interactions 
and aggressivity index are shown at the bottom. Chemogenetic stimulation of MRR vGluT2-neurons lead to 
highly aggressive behavior, suggesting the induction of active coping with a perceived strongly negative 
experience. 
D: Testing anhedonia in a sucrose preference test (see Suppl. Methods for details).  Chronic stimulation of MRR 
vGluT2-neurons (in hM3Dq-mice) lead to a significant difference in sucrose preference compared to CTRL-
mice, suggesting the induction of depression-related anhedonia. Graphs show medians and 25%-75% quartiles. 
For statistical details see Suppl. Data for Fig. 6. 
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Fig. 7: MRR vGluT2-neurons selectively innervate PV-positive MS/VDB neurons 
 
 
A: AAV2/5-EF1α-DIO-eYFP was injected into the MRR of vGluT2-Cre mice (n=3). 
B: MRR vGluT2-neuronal fibers innervate the MS/VDB. Scale bar: 200 μm. 
C: A representative MS/VDB PV-positive neuron (red) is innervated by basket-like multiple synapses of 
vGluT2-positive MRR fibers (green), establishing Homer 1-positive (white) synaptic contacts (white 
arrowheads). Scale bar: 10 μm. (For statistical details see Supplementary Data for Fig. 7) 
D-E: Electron microscopic images show serial sections of synapses of vGluT2-positive MRR terminals (dark SI-
DAB). D: PV-positive dendrite (false red colored, DAB-Ni precipitate) in the VDB received synaptic contacts (at 
least 12 synapses were reconstructed, black arrowheads) E: Synapses contained GluN2A subunit of the 
NMDA-receptors (immunogold labeling, black arrowheads) postsynaptically. Scale bar: 300 nm. (For 
statistical details see Supplementary Data for Fig. 7) 
F: AAV2/5-EF1α-DIO-mCherry was injected into the MRR and FluoroGold into the bilateral hippocampi of 
vGluT2-Cre mice (n=2). 
G: Representative injection sites in the hippocampus (green FluoroGold, FG labeling) and MRR (red AAV-
mCherry). Scale bars: 200 μm. 
H: AAV-mCherry containing vGluT2-positive MRR terminals (red) establish several putative contacts (white 
arrowheads) with a FluoroGold (FG)-positive (green) septo-hippocampal PV-positive (blue) neuron. Scale bar: 
10 μm. 
I: Double retrograde tracing was performed by injecting FluoroGold into the MS/VDB and CTB into the LHb, 
bilaterally, and AAV2/5-EF1α-DIO-mCherry was injected into the MRR to virally label vGluT2-positive neurons 
in vGluT2-Cre mice (n=2). 
J: Representative injection sites in the MS/VDB (FluoroGold, FG, labeling) and in the LHb (CTB labeling). Scale 
bars: 200 μm. 
K: MRR vGluT2-neurons (red) contain both FG (green) and CTB retrograde labeling (blue) shows that bifurcating 
axons of these neurons simultaneously target both MS/VDB and LHb. (For statistical details see Supplementary 
Data for Fig. 7) Scale bar: 20 μm.  
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Fig. 8: MRR vGluT2-neurons promote hippocampal theta-rhythm and are necessary for fear memory 
formation. 
 
 
 
A: AAV2/5-EF1a-DIO-ChR2-eYFP was injected into the MRR of vGluT2-Cre mice. An optical fiber was inserted 
into the MRR and a silicone probe was implanted into the hippocampal CA1 region to measure concurrent 
hippocampal network activity (n=7 mice). Mice were head-fixed on top of an air supported spherical treadmill 
and their behavior was monitored. 
B: Bottom panel: running speed, middle panel: local field potential (LFP) recordings from the pyramidal layer 
of the dorsal hippocampal CA1 region, top panel: corresponding wavelet spectrogram. Vertical dashed line 
indicates the onset of laser stimulation, which rapidly induced a switch to theta oscillation. 
C: Bottom panel: average running speed (mean +/- SEM), top panel: corresponding averaged wavelet 
spectrogram (7 mice). Vertical dashed lines highlight the MRR laser illumination period. 
D: Paired plots indicating movement speed (left panel) and theta/delta ratios (right panel) during baseline (10 
s long window before laser onset) vs stimulation (10 s long window after laser onset) periods (grey: individual 
animals, black: mean +/- SEM. For statistical data see Suppl. Data for Fig.  8). 
E: Design of cued fear conditioning experiments with optogenetic inhibition of MRR vGluT2-neurons. 
Fluorescent image represents one of the injection sites to label MRR vGluT2-neurons and the orange area 
represents the position of the optic fiber (scale bar: 500 μm). After handling, light-illumination of MRR was 
switched on precisely during foot-shocks that mice received at the end of the auditory cue presentation on 
day 6. On day 7 and 8 mice received no more light. On day 7, contextual freezing behavior in ArchT-mice in the 
same environment was almost completely diminished (below 5% threshold) compared to CTRL-mice, which 
received virus without ArchT. On day 8, ArchT-mice showed significantly less generalized fear and cued fear in 
a novel environment compared to CTRL-mice (For statistical details see Suppl. Data for Fig. 8). Medians and 
interquartile ranges are shown on the graphs.  
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Supplementary Methods 
 
Ethical considerations 
All experiments were performed in accordance with the Institutional Ethical Codex and the Hungarian 
Act of Animal Care and Experimentation guidelines (40/2013, II.14), which are in concert with the European 
Communities Council Directive of September 22, 2010 (2010/63/EU). The Animal Care and Experimentation 
Committee of the Institute of Experimental Medicine of Hungarian Academy of Sciences and the Animal Health 
and Food Control Station, Budapest, have also approved the experiments under the project numbers 
PEI/001/33-4/2013, PE/EA/2553-6/2016 and PE/EA/254-7/2019.  
 
Mice 
The following mice were used in the experiments: males and females of vGluT2-iRES-Cre, vGAT-iRES-
Cre, BAC-vGluT3/iCre, TpH2/iCre-ERT2 (The Jackson Laboratory) and males of C57Bl/6 wild type (Charles River). 
We used adult, at least 6 weeks-old mice. Mice had access to food and water ad libitum and were housed in a 
vivarium (3-5 mice/cage) until used in experiments, after which they were single-housed. Mice used for 
optogenetic behavioral experiments were maintained on a normal 12h light-dark cycle, with experiments 
performed during the light phase of the cycle. Mice used for chemogenetic behavioral experiments were 
maintained on a reversed 12h light-dark cycle, with experiments performed during the dark phase of the cycle. 
 
Stereotaxic surgeries for viral gene transfer, retrograde tracing and optic fiber implantations 
Mice were anesthetized with 2% isoflurane followed by an intraperitoneal injection of an anesthetic 
mixture (containing 8.3 mg/ml ketamine and 1.7 mg/ml xylazine-hydrochloride in 0.9% saline, 10 ml/kg body 
weight); and were then mounted in a small animal stereotaxic frame (David Kopf Instruments, CA, USA) and 
the skull surface was exposed. A Nanoject II precision microinjector pump (Drummond, Broomall, PA) was used 
for the microinjections. For anterograde tracing, optogenetic and chemogenetic experiments, we injected 10-
100 nl and for stereological measurements 1000-1200nl of one of the following viruses into the target brain 
areas: AAV2/5-EF1α-DIO-eYFP; AAV2/5-EF1α-DIO-mCherry; AAV2/5-EF1α-DIO-hChR2(H134R)-eYFP; AAV2/5-
CAG-FLEX-ArchT-GFP (UNC Vector Core for the viruses above), AAV2/8-hSyn-DIO-mCherry and AAV2/8-hSyn-
DIO-hM3D(Gq)-mCherry (Addgene; 4.4-21×1012 colony forming units/ml for all viruses). For retrograde tracing 
experiments we injected 20-40 nl of 2% FluoroGold (Fluorochrome, Denver, CO, USA) or 0.5% Choleratoxin B 
subunit (List Biologicals, Campbell, CA, USA) into the target areas. The coordinates for the injections were 
defined by a stereotaxic atlas (Paxinos & Watson 2012); the null coronal plane of the anteroposterior (AP) axis 
was defined by the position of Bregma; the null sagittal plane of the mediolateral (ML) axis was defined by the 
sagittal suture; the null horizontal plane of the dorso-ventral (DV) axis was defined by the bregma and lambda. 
The median raphe region (MRR) was defined as the median raphe and the para-median raphe areas together. 
The injection coordinates were the following (always given in mm at the AP, ML and DV axes, respectively): 
median raphe region: -4.5, 0.0, -4.5 or -4.1, 0.0, -4.6; median raphe region for stereology (4 injections 
altogether): -4.3, 0.0, -4.3 and -4.8 and -4.7, 0.0, -4.1 and -4.6; lateral habenula: -1.5; +/- 0.5; -2.8; 
hippocampus: (2-2 injections bilaterally) -2.0, +/- 1,5, -2 and -2.7, +/- 2.5, -2.7; VTA: -3.4, +/- 0.2, -4.5; medial 
septum: +1.0, 0.0, -4.3; vertical limb of the diagonal bands of Broca (VDB): +1.0, 0.0, -5.2; medial prefrontal 
cortex (1-1 injection bilaterally): + 1.8, +/- 0.3 and -2.7. 
For behavioral experiments, during a second, similar surgical procedure 4-6 weeks after virus 
injections, optic fibers (105 μm core diameter, 0.22 NA, Thorlabs GmbH, Dachau/Munich, Germany) were 
implanted into the MRR with the tip at the following coordinates: -4.5, 0.0, -4.4. Positions of the optic fibers 
are illustrated in Suppl. Fig. 5. After the surgeries, mice received 0.3-0.5 ml saline and 0.03-0.05 mg/kg 
meloxicam (Metacam, Boehringer Ingelheim, Germany) intraperitoneally or 0.1 ml buprenorphine (0.1 mg/kg; 
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Bupaq) subcutaneously and were placed into separate cages to rest, until further experiments or perfusions. 
Following two weeks of recovery, animals used in chemogenetic experiments were moved to the behavioral 
examination unit and adapted to reversed lighting cycle for another 2 weeks before behavioral experiments 
started. 
 
Mono-trans-synaptic rabies tracing 
A detailed description of the monosynaptic rabies tracing technique used has already been published 
by (26). Briefly, vGluT2-Cre mice were prepared for stereotaxic surgeries as described above, and 30 nl of the 
virus AAV2/8-hSyn-FLEX-TVA-p2A-eGFP-p2A-oG (Salk GT3 Core, 4.5×1012 colony forming units/ml) was 
injected into the MRR at the coordinates given above. These Cre-dependent viruses contain an avian tumor 
virus receptor A (TVA), which is necessary for them to be infected by the rabies viruses and they contain an 
upgraded version of the rabies glycoprotein (oG) that provides an increased trans-synaptic labeling potential 
for the rabies viruses (68). After 2-3 weeks of survival, mice were injected with the genetically modified 
Rabies(ΔG)-EnvA-mCherry (Salk GT3 Core, 3.5×107 colony forming units/ml) at the same coordinates. After 10 
days of survival, mice were prepared for perfusions. 
 
Perfusions 
Mice were anesthetized with 2% isoflurane followed by an intraperitoneal injection of an anesthetic 
mixture (containing 8.3 mg/ml ketamine, 1.7 mg/ml xylazine-hydrochloride, 0.8 mg/ml promethazinium-
chloride) to achieve deep anesthesia. The mice were then perfused transcardially with 0.1M phosphate-
buffered saline (PBS, pH 7.4) solution for 2 min, followed by of 4% freshly depolymerized paraformaldehyde 
(PFA) solution for 40 min, followed by PBS for 10 min, then the brains were removed from the skull (protocol 
A). Animals used in chemogenetic behavioral experiments were perfused with 0.1M phosphate buffered saline 
(PBS) for 1 minutes, then with 4% PFA in PBS for 20 minutes. Brains were taken out and post-fixed for 24 h in 
fixative at 4°C then cryoprotected by 20% glucose-PBS solution for 24 hours at 4°C (protocol B). For block-face 
scanning electron microscopy, mice were perfused with 0.1M phosphate-buffered saline (PBS, pH 7.4) solution 
for 30 sec, followed by a fixative solution containing 2% PFA and 1% glutaraldehyde (GA) and 15% picric acid 
for 5 minutes (all salts were obtained from Sigma-Aldrich); the brains were then removed from the skull on 
ice, cut sagittally and coronally into 5 pieces and immersion fixed in 4% PFA and 0,1% GA in 0.1 M phosphate-
buffer (PB, pH 7.4)  for 4 hours at room temperature, then the fixative was washed out with 0.1 M PB (protocol 
C). After perfusions brains were cut into 30 μm-thick sections using a sliding microtome or to 50, 60 or 100 
μm-thick sections using a vibrating microtome (Leica VT1200S or Vibratome 3000). 
 
Antibodies 
The list and specifications of the primary and secondary antibodies used can be found in Suppl. Table 
S1-S2. The specificities of the primary antibodies were extensively tested, using either knock-out mice or other 
reliable methods. Secondary antibodies were extensively tested for possible cross-reactivity with the other 
antibodies used, and possible tissue labeling without primary antibodies was also tested to exclude auto-
fluorescence or specific background labeling. No specific-like staining was observed under these control 
conditions. Combinations of the used primary and secondary antibodies in the different experiments are listed 
in Supplementary Table S3-S4. 
 
Fluorescent immunohistochemistry and laser-scanning confocal microscopy 
 Perfusion-fixed sections were washed in 0.1 M PB (pH 7.4), and incubated in 30% sucrose overnight 
for cryoprotection. Sections were then freeze-thawed over liquid nitrogen three times for antigen retrieval. 
Sections were subsequently washed in PB and Tris-buffered saline (TBS, pH 7.4) and blocked in 1% human 
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serum albumin in TBS (HSA; Sigma-Aldrich) and then incubated in a mixture of primary antibodies for 48-72 h. 
This was followed by extensive washes in TBS, and incubation in the mixture of appropriate secondary 
antibodies overnight. We used DAPI staining (Sigma-Aldrich) to visualize cell nuclei. Then, sections were 
washed in TBS and PB, dried on slides and covered with Aquamount (BDH Chemicals Ltd) or with Fluoromount-
G Mounting Medium (Invitrogen). For the viral anterograde and retrograde tracing experiments, each injection 
site was reconstructed from 50 µm sections using a Zeiss Axioplan2 microscope. Every part of the injected 
tissue containing even low levels of tracer was considered as part of the injection site. Sections were evaluated 
using a Nikon A1R confocal laser-scanning microscope system built on a Ti-E inverted microscope with a 10× 
air objective or with a 0.45 NA CFI Super Plan Fluor ELWD 20XC or with a 1.4 NA CFI Plan Apo VC 60× oil 
objective or with a Nikon Ni-E C2+ confocal system equipped with a 0.75 NA Plan Apo VC DIC 20× objective, 
both operated by NIS-Elements AR 4.3 software. Regions of interests were reconstructed in z-stacks; distance 
between the focal planes was 0.5 μm for examined synaptic contacts and 2 μm for examined neuronal somata. 
In case of the monosynaptic rabies tracing experiments, coronal sections spaced at 300 μm were prepared 
from the whole brain for confocal laser-scanning microscopy, and every trans-synaptically labeled cell was 
scanned using a Nikon Ni-E C2+ confocal system equipped with a 0.13 NA Plan Fluor 4× objective operated by 
NIS-Elements AR 4.3 software. The cell counting was performed using the Adobe Photoshop CS6 software. 
 
Immunoperoxidase labeling for virus injection localization in chemogenetic experiments 
Red fluorescent protein (RFP) was labeled with a rabbit polyclonal antibody (Rockland 
Immunochemicals, Inc., Pennsylvania, USA). The primary antibody was detected by biotinylated anti-rabbit 
goat serum (Rockland Immunochemicals, Inc., Pennsylvania, USA) and avidin–biotin complex diluted in TBS 
(1:1000, Vectastain ABC Kit, Vector Laboratories, USA). The peroxidase reaction was developed in the presence 
of diaminobenzidine tetrahydrochloride (0.2mg/ml), nickel–ammonium sulphate (0.1%) and hydrogen 
peroxide (0.003%) dissolved in TBS. The sections were mounted on glass slides and covered by a DPX mounting 
medium. 
For identification of virus location, microscopic images were digitized by an OLYMPUS CCD camera 
using a 4x magnification lens. The extent and anatomical localization of viral gene expression was determined 
by the atlas of Paxinos and Franklin (2012). 
 
Immunogold-immunoperoxidase double labeling and electron microscopy 
Perfusion-fixed sections were washed in 0.1 M PB for 1 hour, then cryoprotected by incubation in 30% 
sucrose overnight and freeze-thawed three times over liquid nitrogen. For synaptic detection of N-methyl-D-
aspartate (NMDA) receptor GluN1 or GluN2A subunit, sections were pretreated with 0.2 M HCl solution 
containing 2 mg/ml pepsin (Dako) at 37°C for 6 min. Then sections were blocked in 1% HSA in TBS, followed by 
incubation in a mixture of primary antibodies. After repeated washes in TBS, sections were incubated in 
blocking solution (Gel-BS) containing 0.2% cold water fish skin gelatin (Aurion) and 0.5% HSA in TBS for 1 h. 
Sections were then incubated in mixtures of secondary antibody solutions overnight. After intensive washes 
in TBS, the sections were treated with 2% glutaraldehyde in 0.1 M PB for 15 min to fix the gold particles in the 
tissue. To develop the labeling for MRR vGluT2 fibers, this was followed by incubation in avidin-biotinylated 
horseradish peroxidase complex (Elite ABC; 1:300; Vector Laboratories) diluted in TBS for 3 h. The 
immunoperoxidase reaction was developed using 3-3′-diaminobenzidine (DAB; Sigma-Aldrich) as chromogen. 
To enlarge immunogold particles, this was followed by incubation in silver enhancement solution (SE-EM; 
Aurion) for 40-70 min at room temperature. The sections were treated with 0.5% osmium tetroxide in 0.1 M 
PB on ice and they were dehydrated in ascending ethanol series and in acetonitrile and embedded in Durcupan 
(ACM; Fluka). During dehydration, the sections were treated with 1% uranyl-acetate in 70% ethanol for 20 min. 
After this, 70-100nm serial sections were prepared using an ultramicrotome (Leica EM UC6) and collected on 
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single-slot copper grids. Sections were examined using a Hitachi H-7100 electron microscope and a Veleta CCD 
camera driven by the iTEM 5.0 software (Olympus). Randomly sampled terminals of the MRR establishing 
synaptic contacts in the LHb and MS/VDB were always fully reconstructed. 
 
Silver-gold intensified and nickel-intensified immunoperoxidase double labeling (SI-DAB/DAB-Ni) 
 Perfusions, sectioning and incubations of sections in primary antibody solutions were performed as 
described above. In the SI-DAB reaction, it was followed by subsequent washes in the appropriate secondary 
antibody solutions for 24h in TBS. After subsequent washes in TBS and incubation in avidin-biotin-peroxidase 
complex for 3 h (ABC Elite 1:300, Vector Laboratories), ammonium nickel sulphate-intensified 3-3’-
diaminobenzidine (DAB-Ni) was used for the development of immunoperoxidase reaction. This reaction was 
further intensified with silver-gold (SI-DAB) as described in detail in Dobó et al. 2011. This intensification step 
converts the labeling from homogenous to granular by loading fine gold particles onto the DAB-Ni deposit. 
After washes in TBS, sections were blocked in 1% HSA for 1 h and incubated in primary antibody solutions for 
the second DAB-Ni reaction for 48-72 h. This step was followed by incubation with an ImmPRESS secondary 
antibody solution overnight. The second immunoperoxidase reaction was developed by DAB-Ni, resulting in a 
homogenous deposit, which was clearly distinguishable from the silver-gold intensified SI-DAB at the electron 
microscopic level (69). Further dehydration, contrasting and processing of the sections for electron microscopy 
was performed as described above. 
 
Sample preparation for 3D block face scanning electron microscopy (BF-SEM) 
 Virally injected vGluT2-Cre mice, 4-6 weeks after the injection, were sacrificed for BF-SEM 
experiments. Mice were anesthetized and perfused according to “protocol C” as described above. 100 μm-
thick sections were cut using a vibrating microtome from the blocks containing the lateral habenula and 50 
μm-thick sections were cut from the blocks containing the MRR. Sections were washed in PB for 1 hour, then 
cryoprotected by incubation in 30% sucrose overnight and freeze-thawed three times over liquid nitrogen. 
Then, sections were blocked in 1% HSA in TBS, followed by incubation in a mixture of primary antibodies. After 
repeated washes in TBS, sections were incubated in blocking solution (Gel-BS) containing 0.2% cold water fish 
skin gelatin (Aurion) and 0.5% HSA in TBS for 2 h. Sections were then incubated in mixtures of secondary 
antibody solutions for 2 days. After intensive washes in TBS, the sections were treated with 2% glutaraldehyde 
in 0.1 M PB for 30 min to fix the gold particles in the tissue. Then gold conjugated secondary was intensified 
with GOLDENHANCE™ EM Plus Kit (Nanoprobes). To get high contrast for BF-SEM equipped with field emission 
gun, we used a modified protocol of Deerinck et al. (70). Briefly, sections were postfixed in 1% osmium-
tetroxide reduced with 0,75% potassium ferrocyanide, on ice for 1 hour, followed by thiocarbohydrazide (TCH) 
incubation for 30 minutes. Then sections were treated with 1% osmium-tetroxide solution for 30 minutes, and 
then for another 30 minutes with 1% aqueous uranyl-acetate in dark. Then, en bloc Walton’s lead aspartate 
staining was performed at 60°C for 30 minutes. After each step, sections were washed 5 x 3 minutes in distilled 
water. Finally, the sections were dehydrated through ascending ethanol series on ice (from 30% to absolute 
ethanol for 2x5 minutes) and then infiltrated with acetonitrile for 2 x 10 minutes (first on ice, second at room 
temperature). The sections were transferred into aluminum boats and infiltrated with embedding resin (Epoxy 
Embedding Medium Kit, Sigma-Aldrich, hard mixture) overnight. The next day, sections were mounted on glass 
slides, covered and baked at 60°C for 48 hours. After baking, a small region of interest was cut out with razor 
blade and mounted on an aluminum specimen pin with Silver Conductive Epoxy, H2OE EPO-TEK® (Ted Pella) 
and baked at 60°C for 48 hours. After the conductive epoxy was polymerized, samples were trimmed with an 
ultracut (EM UC6, Leica, Wetzlar, Germany) to create a cube with a glass knife. The cube shaped block (~ 400 
μm x 400 μm x 75 μm) was sputter coated with gold using a Rotary-Pumped Sputter Coater (Quorum 
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Technologies, Q150R ES). The samples were stored in dust free holders and they were transferred into the 
vacuum chamber for at least one night before using them for BF-SEM imaging. 
 
BF-SEM imaging and image analysis 
 We used a FEI Apreo field emission gun (FEG) SEM equipped with an in situ ultramicrotome 
(VolumeScope, FEI, Eindhoven, The Netherlands) and a T1 “in column” detector to record the backscattered 
electrons (BSE) from each voxel. For all image stacks, we collected BSE images with MAPs software from 6,5 
mm working distance at high vacuum with fixed 0,1 nA beam current, 2.27 kV high voltage, 1,25 μs pixel dwell 
time, with a voxel size of 4 nm x 4 nm x 70 nm. The images in the z-stacks measured 16384x16383 pixels with 
70 nm thickness, and the final z-stacks contained 300 such slices, so the overall volume for each animal was 
cca. 90 200 μm3. All image post-processing was done in Fiji. The BF-SEM stacks were imported into FIJI ImageJ 
TrakEM2 and fine aligned. For segmentation, we used area lists for axonal profiles, mitochondria, and profile 
lists for synapses. Manual segmentation was performed on a Wacom Cintiq 27QHD Creative Pen and display 
tablet. After, synaptic surface measurements were finished using the built-in plugin of TrakEM2, data were 
retrieved by custom made excel datasheet and analyzed with Tibco Statistica 13.4. After segmentation, the 
models were exported in .obj format and imported into Blender (Blender Foundation, Amsterdam, The 
Netherlands) for further investigation and visualization. 
 
Stereology measurements 
Unbiased design-based stereological measurements were carried out using the optical fractionator 
method (71–73), which is based on the principle that one can accurately define the number of cells in the 
volume of interest by counting them in a predetermined fraction of the given volume (74). To get the total cell 
numbers, the number of counted cells is multiplied by the reciprocal of three different fractions: section, area, 
and thickness sampling fractions (75). Using systematic random sampling in each experiment, every second 
section of the MRR was used; therefore, section sampling fraction was 0.5. In mounted sections, cells were 
counted only within a fraction of a predefined grid area. In the MRR, this fraction was 152/802 µm, in the para-
median raphe, this fraction was 102/802 µm. Finally, thickness sampling fraction was 15/28 µm, because the 
average mounted section thickness was 28 µm and counting was performed only in a 15-µm-high counting 
cube. We used a guard zone of minimum 5 µm of tissue above and below the counting cube; however, for 
maximum accuracy, thickness sampling fractions were determined at every sampling site. Cells were counted 
inside the counting cubes or if they touched one of the 3 inclusion planes of the counting cubes. Cell counting 
was carried out in Stereo Investigator 10.0 stereology software (MBF Bioscience), while cells were identified 
parallel using NIS Elements AR 4.3 software. 
 
In vitro slice preparation 
In all slice studies, mice were decapitated under deep isoflurane anesthesia. The brain was removed 
and placed into an ice-cold cutting solution, which had been bubbled with 95% O2/5% CO2 (carbogen gas) for 
at least 30 min before use. The cutting solution contained the following (in mM): 205 sucrose, 2.5 KCl, 26 
NaHCO3, 0.5 CaCl2, 5 MgCl2, 1.25 NaH2PO4, 10 glucose. Then, coronal slices of 300 µm thickness were cut using 
a Vibratome (Leica VT1000S). After acute slice preparation, slices were placed into an interface-type holding 
chamber for recovery. This chamber contained standard ACSF at 35°C that gradually cooled down to room 
temperature. The ACSF solution contained the following (in mM): 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2, 2 
MgCl2, 1.25 NaH2PO4, 10 glucose saturated with carbogen gas. NBQX was ordered from Hello Bio Inc., and AP-
5 was from Tocris Bioscience. Drugs were administered from stock solutions via pipettes into the ACSF 
containing superfusion system. All other salts were obtained from Sigma-Aldrich or Molar Chemicals KFT. 
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Intracellular recordings 
The composition of the intracellular pipette solution was the following (in mM): 110 K-gluconate, 4 
NaCl, 20 HEPES, 0.1 EGTA, 10 phosphocreatine, 2 ATP, 0.3 GTP, 3 mg/ml biocytin adjusted to pH 7.3–7.35 using 
KOH (285–295 mOsm/L). Whole-cell series resistance was in the range of 5–15 MΩ. Series resistance was not 
compensated, but was frequently monitored, and cells, where the values changed more than 25% during 
recording were discarded from further analysis. Voltage measurements were not corrected for the liquid 
junction potential. To record glutamatergic currents, membrane potential was clamped far (~ 65 mV) from α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/NMDA-R reversal potential. To block AMPA and 
NMDA currents, NBQX (20 μM) and AP-5 (50 μM) were added to the recording solution. For illumination, we 
used a blue laser diode (447 nm, Roithner LaserTechnik GmbH) attached to a single optic fiber (Thorlabs) 
positioned above the lateral habenula. 
 
Digital signal processing, analysis and statistics for in vitro experiments 
All data were processed and analyzed off-line using standard built-in functions of Python 2.7.0. Latency 
was defined as a time between light stimulus onset and time of reaching 10% of maximal EPSC amplitude. 
Throughout this manuscript, for in vitro electrophysiology data, we used median, first, and third quartiles for 
the description of data groups because they did not show Gaussian distribution. 
 
Stereotaxic surgeries for electrophysiological recordings in head-fixed mice 
Animals were anesthetized with isoflurane and mounted in a stereotaxic frame (David Kopf 
Instruments, Tujunga, CA). The cranium was exposed, the bone was dried. For the future hippocampal and 
median raphe recording sites, 2 cranial windows (1.5 mm width), and for the optical fiber, a hole (0.5 mm 
diameter) were drilled into the cranium (from Bregma: 2.5 mm caudal and 2.5 mm lateral for the hippocampal 
window; 6.2 mm caudal and 0 mm lateral for median raphe window and 4.5 mm caudal and 0 mm lateral for 
the optical fiber). A hole was drilled above the cerebellum for the insertion of the ground electrode. A head-
plate was fixed to the skull surface using dental acrylate (Paladur). Finally, the skull surface and the holes were 
covered with a silicone sealant. After surgery, the mouse was continuously monitored until recovered, as 
demonstrated by their ability to maintain sternal recumbence and to exhibit purposeful movement. 
 
In vivo electrophysiological recording  
After a recovery period of 3-7 days, the mice were water restricted and habituated for 10 to 14 days 
to the spherical treadmill setup with their head fixed. The animal weights were monitored and when a mouse 
reached 85% of the initially measured baseline weight, the daily volume of water supplement was individually 
adjusted in order to maintain this 85 % target weight. During the habituation period the animals learned to 
took water drops from a lick port positioned in front of the animals’ mouth.  
On the day of the experiment the animal was head-fixed above the air supported spherical treadmill. 
Hippocampal silicone probe (Buzsaki32 or Buzsaki64 type silicon probe, NeuroNexus, Ann-Arbor, MI) was 
lowered through the cranial window into the hippocampal CA1 pyramidal layer.  The pyramidal layer was 
identified physiologically by increased unit activity and the occurrence of ripple events.  The optical fiber was 
lowered to a 4.2 mm depth from the skull surface. The median raphe probe (Buzsaki32 or Poly5 type silicon 
probe, NeuroNexus, Ann-Arbor, MI) was inserted and lowered to a depth of 4.4 mm in an angle of 20 degree 
from caudal. Before the insertion of the probe and the optical fiber, they were coated with the lipophilic 
fluorescent dye, Dil (Thermo Fischer Scientific) for later histological verification of their location. Ground 
electrode was placed above the cerebellum.   
The median raphe probe was advanced by a micromanipulator until multiple median raphe unit activity 
was detected in a depth of 4-8-5.2 mm. Once the probes were positioned at their final position, recording was 
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started. Following a 10-15 minutes baseline recording period LED flash (200 ms, yellow), air puff (200 ms) and 
rewarding water drops were applied at random intervals. Electrophysiological recordings were performed by 
a signal multiplexing head-stage. Signals were acquired at 20k sample/s (KJE-1001, Amplipex Ltd, Hungary). 
Mouse locomotor activity was recorded with an optical computer mouse positioned close to the spherical 
treadmill at the equator.  
To represent the spectral components of hippocampal LFP activity on Fig. 4 we obtained the Morlet 
wavelet decomposition of the hippocampal recording. For calculating the theta to delta ratio, hippocampal LFP 
oscillations (delta: 1-4 Hz, theta: 5-12 Hz) were separated on the basis of the Hilbert magnitude of the band-
pass-filtered signal. The average Hilbert magnitudes were calculated before and during the laser stimulation 
(in 10 s long windows) and ratios (average theta / average delta magnitudes) were calculated in each period. 
All in vivo data were analyzed in Igor Pro 8 (Wavemetrics). 
 
Optogenetical tagging 
At the end of each recording session brief laser pulses were applied (n = 30, 1 ms at 4 Hz, 473 nm) for 
offline identification of responsive units. Units were categorized as “tagged” if followed the laser pulse with 
short latency (within 4 ms) and more than 50 % success rate. 
Neuronal spikes were detected and automatically sorted from the high-pass filtered local field 
potential recordings (0.5–5 kHz) by a template matching algorithm Spyking-Circus (76), followed by manual 
adjustment of the clusters using the Phy software (77) to obtain well-isolated single units. Cluster isolation 
quality was estimated by calculating the interspike interval index for each cluster (78); poor quality clusters 
were discarded.  
 
Quantification and statistical analysis of in vivo physiological experiments 
The mean baseline firing rate values and standard deviations were calculated from a 4 second time 
window preceding stimulus onset. Changes in firing rate was declared significant if it deviated more than 2 
standard deviations from the mean baseline value (z-score larger than 2 or smaller than -2) in a 200 ms time 
window after stimulus onset. Both responsive and non-responsive neurons distributed across animals. 
All statistical analyses were performed with standard Igor Pro 8 functions. For paired comparisons the 
Wilcoxon signed rank test was used. All graphs indicate mean +/- SEM. For significance, p = 0.05 was used. 
 
Real time place aversion (RTPA) and conditioned place aversion (CPA) tests 
 After optic fiber implantations, mice were transferred to the animal room of the behavioral unit of the 
institute to rest, then they received 5 days of handling. On the 6th day (habituation day), mice were placed 
into a chamber (40 cm x 20 cm x 20cm, divided into two areas with striped walls and floor on the one side and 
dotty walls and floor on the other side) for habituation for 10 min. After each experiment, the chamber was 
washed with “macadamia-scented” soap. On the 7th day (real-time place aversion), mice were placed in into 
the non-stimulated side of the chamber and left moving freely for 15 min. Blue laser stimulation (5 ms pulses 
at 25Hz with 10-15mW intensity, 473 nm) started when the animal entered the stimulation side. On the 8th 
day (conditioned place aversion) mice were tested without laser stimulation for 5 min in the same chamber. 
The experiments were performed in a counter-balanced way, some mice received stimulation in the striped 
side, while others in the dotty side, to exclude the possibility of innate aversion for any context. The behavior 
of the mice was recorded with a Basler acA1300-60gc camcorder. Experimental data were collected and 
analyzed using the Noldus EthoVision 13.0 and Tibco Statistica 13.4 software. 
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Statistical analysis and evaluation of RTPA and CPA data 
To precisely examine whether mice distinguished the stimulated and non-stimulated sides in the RTPA 
and CPA paradigms, the chamber was divided into three virtual areas: a stimulation area, a non-stimulated 
area and a so-called decision zone. The decision zone was a rectangle with an area of 14 cm x 8 cm (14% of the 
total chamber area of 800 cm2) placed in the middle of the chamber. We excluded the time spent in the 
decision zone to exclude any possible uncertainty of the detection of the position of the mice in the middle of 
the chamber. To define the percentage of time spent by the mice in the different contexts, we divided the time 
spent in the stimulation area with the sum of the time spent in the stimulation area plus the non-stimulated 
area.   
 
Operant conditioning 
On the 9th day (after RTPA and CPA tests), mice were started to be kept on a diet to keep their body 
weight between 80%-90% of the original. They were also habituated to the reward pellets (Bio-Serv, NJ, USA) 
used in the operant conditioning paradigm for 3 days. The diet was held for the whole duration of the operant 
conditioning tests to support the motivational drive to poke for pellet rewards.  
On the 12th day (Fig. 5C), mice were put in an automatized operant conditioning chamber system (Med 
Associates Inc., VT, USA), and they were conditioned to nose-poke for pellet rewards (45mg) for 30 
minutes/day for 10 days. The chamber was put in a dark box, but it was lit by a house light. Every correct nose-
poke was followed by a 15 seconds-long interval, when the house light turned off and mice did not receive 
pellet rewards even if they performed nose-pokes. This interval was inserted into the experiment to help the 
mice learn the conditioning rule, and to allow them time to consume the pellets. After this interval, mice could 
perform a correct nose-poke again to receive pellets. The number of total nose-pokes was defined as the sum 
of the correct nose-pokes and the interval nose-pokes.  
The operant conditioning chambers were washed after every individual mouse with distilled water. 
From the 20th day, mice were connected to a dummy fiber patch for habituation. On the 22th day (poke 
stimulation), mice received 5 seconds blue laser stimulation (5 ms pulses at 25Hz with 10-15mW intensity, 473 
nm), after every correct nose-poke. After the 30 min stimulation period, mice were placed back into their home 
cages and received food ad libitum again for 3 days to regain their original weight. 
 
Statistical analysis and evaluation of operant conditioning tests 
We compared the number of total-nose pokes performed by the individual mice in a pairwise manner 
between the 21th (poke baseline) and 22th (poke stimulation) days of the experiment. Then, we normalized 
the number of the total nose-pokes performed by a mouse on the 22th day to the number of the total nose-
pokes performed by the same mouse on the 21th day, respectively (Poke ratio, stimulation/base). These ratios 
were compared between the groups of ChR2-expressing and CTRL virus expressing mice. 
 
Optogenetic contextual fear conditioning (Opto-CFC) 
 After operant conditioning, mice rested for 3 days to regain their original weight. On the 25th day, 
mice were placed into a plexiglass foot-shocking chamber (Suppl. Fig. 6C, 25 cm × 25 cm × 31 cm) that was 
enriched with a specific combination of olfactory (baby soap scent), visual (grey wall), spatial (rectangular 
chamber walls) and tactile (metal bars on the floor) cues. Mice were allowed to freely move in the environment 
for 3 minutes to record baseline freezing levels. After this, mice received 15 seconds of blue laser stimulation 
(5 ms pulses at 25Hz with 10-15mW intensity, 473 nm) that was repeated 10 times with 15 seconds inter-
stimulation interval. After receiving the last stimulation, mice were kept in the context for another 3 minutes. 
24 hours later, on the 26th day, mice were placed back to the same context to read out freezing levels. The 
behavior of mice was recorded with a Basler acA1300-60gc camcorder, and freezing behavior was analyzed 
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manually using the Solomon Coder (https://solomoncoder.com) software. The experimenter evaluating 
freezing levels was blind to the conditions and treatment of the mice. Mice displaying higher than 5% baseline 
freezing levels were excluded from further analysis.  
 
Delayed cued fear conditioning (CuedFC) 
After optic fiber implantations, mice were transferred to the animal room of the behavioral unit, where 
they received 5 days of handling. On the 6th day, mice were placed into the first environmental context 
(environment “A”) in a plexiglass shocking chamber (25 cm × 25 cm × 31 cm) that was enriched with a specific 
combination of olfactory (macadamia nut scent), visual (black dotted wall with white background), spatial 
(bended chamber walls), auditory (white noise) and tactile (metal bars on the floor) cues. Mice were allowed 
to freely move in the first environment for 3 minutes to record baseline freezing levels. After this, mice received 
3 shocks (2 seconds, 2 mA intensity, 60 seconds inter-shock interval) that were paired with an auditory cue 
(30s long sound at 7500 Hz). The footshocks and the auditory cues were co-terminated each time. Footshocks 
were paired with 6 seconds-long yellow laser light illumination (10-15 mW intensity at the tip of the optic fiber 
at 593 nm wavelength), which was precisely aligned with the shocks, starting 2 seconds before the shock onset 
and finishing 2 seconds after shock offset. After receiving the last shock, mice were kept in the context for 
another 30 seconds. After 3 successfully delivered shocks, mice were placed back into their home cages for 24 
h. On the 7th day, mice were placed back into the environment “A” for 3 minutes to record freezing behavior 
related to the contextual fear memories. 24 hours later, on the 8th day, mice were placed into a second 
environmental context (environment “B”) with distinct olfactory (citrus scent), visual (black and white striped 
wall), spatial (square shaped chamber), auditory (no noise) and tactile (plastic floor) cues. For 3 minutes, 
generalized fear levels were recorded in environment “B”. After this, mice were presented with the auditory 
cue for 1 minute to record freezing behavior related to the cued fear memories. After the termination of the 
auditory cue, mice were kept in the environment “B” for 1 minute to read out post-cue freezing levels. The 
behavior of mice was recorded with a Basler acA1300-60gc camcorder and freezing behavior was analyzed 
manually using the Solomon Coder software. The experimenter evaluating freezing levels was blind to the 
conditions and treatment of the mice. Mice displaying higher than 5% baseline freezing levels in environment 
“A” were excluded from the further analysis. 
 
Behavioral test battery for chemogenetic experiments 
We carried out a series of behavioral tests with mice that were injected either with the hM3Dq-
containing virus (that expressed a clozapine-N-oxide (CNO)-sensitive, excitatory G-protein-coupled receptor 
plus a fluorescent protein) or with a control virus (that expressed only a fluorescent protein). All behavioral 
tests were done between 9:00 am – 1:00 pm, at the early phase of the active period under reversed 12h light-
dark cycle. 48-72h rest was left for the mice between each tests. The test cages were cleaned with 20% ethanol 
between animals in each test. In order to activate the hM3Dq-virus CNO (1mg/kg in 10ml saline, Tocris) was 
injected intraperitoneally 30 minutes before each behavioral test. Not all tests were conclusive either because 
of technical difficulties and/or because of insufficient number of animals for the given test. We briefly describe 
all tests, but give all details only about those that were fully evaluated and reported in this study. On day 1, 
mice were tested in a sociability test, in which two small cylinders were placed in the cage and after 
habituation, an unfamiliar mouse was placed in one of the cylinders. Then a familiar mouse was placed into 
one cylinder and an unfamiliar new mouse was put in the other cylinder. These tests were inconclusive. On 
day 3, we carried out a social interaction test, as described below. On day 5, we tested mice in an elevated plus 
maze test apparatus that had two open and two closed arms, crossed in the middle, perpendicularly with each 
other. Mice were put into the center and could freely explore the apparatus for 5 minutes. These tests were 
inconclusive. On day 8, we carried out a resident intruder test, as described below. On day 10, we tested 
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locomotor activity in a Y-maze test, as described below. On day 12, we explored behavioral changes to cat 
odor. A perforated plastic bottle (50ml) filled with used cat litter was put into one of the corners of the test 
arena and mice could freely explore. These tests were inconclusive. On day 15, we carried out a self-care test, 
in which a few drops of 10% sucrose solution was splashed onto the back of the mice. These tests were 
inconclusive. On day 17, mice were forced to swim for 6 minutes individually in an open glass cylinder with 20 
cm of fresh water at 23–25C. They could not reach the bottom of the tank and were unable to escape. These 
tests were inconclusive. On day 19, we carried out an anhedonia test, as described below. Tests were video 
recorded and analyzed later by an observer blind to the treatment protocols using Ethovision 10.0 (Noldus 
Information Technology, The Netherlands), Solomon Coder (https://solomoncoder.com) or H77 (Mihály 
Dobos-Kovács, 2017) software. After this battery of behavioral tests, mice were sacrificed, and their adrenal 
glands were removed and their weight measured.  
 
Social interaction test 
Social interaction test measures social and anxiety-like and aggressive behavior, and it was performed 
on the day 3 of the battery. Mice were confronted with an unknown conspecific with the same size and 
treatment, in a new environment, with bright illumination, which increases the anxiety-like behavior of mice. 
The day before the test, habituation was carried out for 2x15 min consisting of single housing in the test cage 
(41.3 × 26 × 29.8 cm, GeoMaxi, Ferplast, Italy). This reduced the novelty of the environment, with the aim to 
enhance social behavior during the test. During the test phase, two mice with the same treatment were taken 
together into the test cage for 10 minutes. Duration, frequency and percentage of the following behaviors 
were recorded: social (direct sniffing of the conspecific), aggressive, (biting, chasing, boxing, aggressive 
grooming, offensive upright posture and mounting), defensive (escape from conspecific) and other (exploring, 
grooming). 
 
Resident intruder test 
Resident intruder test was conducted to measure territorial aggression and it was performed on the 
day 8 of the battery (79). A 20% smaller intruder mouse was placed into the subject’s home cage for 10 
minutes. The same parameters were measured as in the social interaction test. These tests were performed 
under red light illumination. 
 
Locomotor activity in Y-maze  
In a Y-maze, we observed the locomotor activity of mice (Suppl. Fig. 4I), and it was performed on the 
day 10 of the battery. The apparatus had three arms (25 cm x 5 cm x 21 cm) at 120 degrees. Mice could freely 
explore the maze for 5 min. 
 
Sucrose preference test  
Anhedonia, a typical symptom of depression, is reflected by neglect of the rewarding sucrose. This test 
was performed on the day 19 of the battery. The experiment started with a habituation phase. On the first 
day, two identical bottles of water were available. One day later, both of the bottles were filled with 1% sucrose 
solution. Then, after 15-hour liquid deprivation, we tested mice for 5 hours in a cage with one bottle of water 
and another one with 1% sucrose solution. Pre-weighted bottles were used. The sucrose preference was the 
percentage of sucrose solution consumed, relative to the total liquid consumption. The formula was as follows: 
SP = (sucrose intake/[sucrose consumption + water consumption]) × 100% 
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Statistics for behavioral and in vivo experiments 
 In case of data groups that did not display a Gaussian distribution, we used median and 25%-75% 
interquartile range to describe data. We used means and standard deviations to describe data groups that 
displayed Gaussian distribution. To test for statistical differences, we used the non-parametric Mann-Whitney 
U-test or parametric Student’s t-test in independent data populations, and we used the Wilcoxon’s signed-
rank test in non-parametric dependent data populations. Statistical difference have always been tested using 
two-sided tests. Homogeneity of variance was tested using F-test and if it was significant then populations 
were compared using nonparametric tests. For indicating significance levels on figures, we used the following 
rules, *: p<0.05, **: p<0.01, ***: p<0.001. 
 
Supplementary Text for Main Figures 1 to 8 
Supplementary Data for Figure 1: 
Fig. 1G: Our measurements in 2 mice showed that at least 47% (369/780) of eYFP-positive MRR terminals 
established synaptic contacts with TH-positive profiles, while at least 61% (97/160) of TH-positive cells received 
at least one synaptic contact from eYFP-positive MRR terminals. 
Fig. 1L: Our measurements in 2 mice showed that at least 39% (201/518) of vGluT2-positive LHb fibers 
established synaptic contacts with vGluT2-positive MRR profiles, and at least 55% (48/88) of MRR vGluT2-
positive cells received at least one synaptic contact from mCherry-labelled LHb terminals. 
Fig. 1P-T: Abbreviations: DR: dorsal raphe; LH: lateral hypothalamus; LDTg: laterodorsal tegmental nucleus; 
LHb: lateral habenula; LPO: lateral preoptic area; MHb: medial habenula; NI: nucleus incertus; PDTg: 
posterodorsal tegmental nucleus; VP: ventral pallidum. 
 
Supplementary Data for Figure 2: 
Fig. 2C: At least 81% (22/27, n=2 mice) of vGluT2-positive MRR synapses established in the LHb contain the 
GluN2A subunit, and 81% (9/11, n=1 mouse) contain the GluN1 subunit of the NMDA-receptors, 
postsynaptically. 
 
Supplementary Data for Figure 3: 
Fig. 3C: Population data showing relative second and third EPSC amplitude distributions compared to the first 
EPSC for 10 cells are as follows (median [25%-75% quartiles]): 2 Hz: 0.80 [0.79-0.94]; 0.78 [0.73-0.90]; 5 Hz: 
0.73 [0.67-0.88]; 0.73 [0.64-0.91]; 10 Hz: 0.79[0.64-0.90]; 0.69 [0.65-0.82]; 20 Hz: 0.71 [0.62-0.84]; 0.78 [0.58-
0.86]. 
Fig. 3D: Population data showing EPSC amplitude distributions in pA are as follows (median [25%-75% 
quartiles]): control conditions: 65.78 [46.29-139.79]; NBQX/AP5: 0 [0-0.15], washout: 33.89 [30.24-60.54]. 
Population data showing latency distributions of the recorded cells in msec are as follows (median [25%-75% 
quartiles]): 2.05 [1.87, 3.05]. 
 
Supplementary Data for Figure 4: 
Fig. 4F: Population data for the activity of tagged MRR vGluT2-neurons in baseline (4 s window before stimulus 
onset) and stimulated conditions (0.5 s window after stimulus onset), respectively are as follows (mean +/- 
SEM). Air puff: 0.41 +/- 0.04 vs 0.99 +/- 0.13, n=41 neurons, p=1.1*10-4. LED flash: CTRL: 0.43 +/- 0.04; STIM: 
0.53 +/- 0.04, n=41 neurons, p=6.9*10-5. Reward: CTRL: 0.38 +/- 0.07; STIM: 0.41 +/- 0.08, n=16 neurons, 
p=0.98; Wilcoxon signed-rank test. Air puff evoked significantly larger response than LED flash (comparing 
percentage elevation of baseline activity, LED: 57.9+/-20.0% vs air puff: 340.9+/-133.3%, n=41, p=4.3*10-4, 
Wilcoxon signed-rank test). By analyzing them separately, we found that no neuron decreased its firing. Firing 
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frequency increased in 18 out of 41 neurons for air puffs, in 3 out of 41 for LED and with a longer latency in 1 
out of 16 neurons for reward. 
 
Supplementary Data for Figure 5: 
Fig. 5B: Population data for the time spent in the stimulated area (% of the sum of the time spent in the 
stimulated area). Results for RTPA test and CPA test for 21 CTRL- and 19 ChR2-mice that received light above 
the MRR (median [25%-75% quartiles]). During habituation (see Fig. S5B) CTRL: 44.10 [32.60-56.19]; ChR2: 
52.84 [43.76-59.03]. During RTPA test, CTRL: 52.52 [44.27-68.72]; ChR2: 18.86 [12.70-36.64]. During CPA test, 
CTRL: 55.98 [37.37-80.27]; ChR2: 28.50 [13.95-54.11]. *: p=0.045, ***: p=3.4x10-4, Mann-Whitney U-test.  
Fig. 5D: Population data for the total number of nose-pokes for rewards at the base and stimulation 
performance for 11 CTRL- and 7 ChR2-mice in the operant conditioning task are as follows (median [25%-75% 
quartiles]). During base performance, CTRL: 39 [23-46]; ChR2: 57 [40-67]. During stimulation performance, 
CTRL: 35 [26-47]; ChR2: 35 [11-46]. *: p=0.018, Wilcoxon signed-rank test. 
Fig. 5E: Population data for the ratios of stimulation/base performance of 11 CTRL- and 7 ChR2-mice are as 
follows: (mean, +/- SD): CTRL: 1.06, +/- 0.47; ChR2: 0.56, +/- 0.31. *: p=0.025, Student’s t-test. 
 
Supplementary Data for Figure 6: 
Fig. 6B: Population data for the percentage of time spent with aggressive behavior in the social interaction test 
for CTRL- and h3MDq-mice, respectively are as follows (median [25%-75% quartiles]): CTRL: 0.00 [0.00-0.00]; 
h3MDq: 6.89 [0.53-11.77]; **: p=0.002, Mann-Whitney U-test. 
Population data for the aggressivity index in the social interaction test for CTRL- and h3MDq-mice, respectively 
are as follows (median [25%-75% quartiles]): CTRL: 0.00 [0.00-0.00]; h3MDq: 37.28 [3.68-52.56]; **: p=0.002, 
Mann-Whitney U-test. 
Fig. 6C: Population data for the percentage of time spent with aggressive behavior in the resident-intruder test 
for CTRL- and h3MDq-mice, respectively are as follows (median [25%-75% quartiles]): CTRL: 0.42 [0.00-0.89]; 
h3MDq: 13.10 [1.17-22.37]. *: p=0.013, Mann-Whitney U-test. 
Population data for the aggressivity index in the resident-intruder test for CTRL- and h3MDq-mice, respectively 
are as follows (median [25%-75% quartiles]): CTRL: 2.14 [0.00-5.37]; h3MDq: 36.05 [3.79-43.89]. *: p=0.032, 
Mann-Whitney U-test. 
Fig. 6D: Population data in the sucrose preference test for CTRL- and h3MDq-mice, respectively are as follows 
(median [25%-75% quartiles]): CTRL: 55.11 [52.21-59.42]; h3MDq: 40.93 [38.60-48.80]. *: p=0.010, Mann-
Whitney U-test. 
 
Supplementary Data for Figure 7: 
Fig. 7C: Our measurements in 2 mice showed that at least 79% (497/626) of vGluT2-positive MRR terminals 
targeted PV-positive profiles, while at least 53% (35/66) of PV-positive cells received at least one contact from 
these vGluT2-positive MRR terminals. 
Fig. 7E: Our measurements in 2 mice showed that at least 67% (14/21) of the synapses of MRR vGluT2-neurons 
contain the GluN2A subunit of the NMDA-receptors, postsynaptically in the MS/VDB. 
Fig. 7K: Our measurements in 2 mice showed that at least 61% (138/225) of the cells projecting to the MS/VDB 
projected to the LHb as well. 
 
Supplementary Data for Figure 8: 
Fig. 8D: Population data in 7 mice for the movement speed of the mice and theta/delta ratios of the 
hippocampal network activity during baseline (10 s long window before laser onset) and stimulation (10 s long 
window after laser onset) periods in arbitrary units are as follows (mean +/- SEM): speed: base: 445.0 +/- 128.9; 
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stim: 2235.3 +/- 646.2, p=0.016, Wilcoxon signed-rank test; theta/delta ratios: base: 1.7 +/- 0.1; stim:  2.6 +/- 
0.2, p=0.016, Wilcoxon signed-rank test. 
Fig. 8E: Population data for the contextual freezing levels (% of total time) in the “A” environment for 13 CTRL- 
and 9 ArchT-mice are as follows (median [25%-75% quartiles]), CTRL: 13.68 [5.67-17.57]; ArchT: 3.00 [0.00-
6.11]. *: p=0.025, Mann-Whitney U-test. 
Population data for the generalized freezing levels (% of total time) in the “B” environment for 13 CTRL- and 9 
ArchT-mice are as follows (median [25%-75% quartiles]), CTRL: 7.77 [1.11-14.33]; ArchT: 0.00 [0.00-2.44]. *: 
p=0.026, Mann-Whitney U-test. 
Population data for the cued freezing levels (% of total time) in the “B” environment for 13 CTRL- and 9 ArchT-
mice are as follows (median [25%-75% quartiles]), CTRL: 52.67 [43.33-59.67]; ArchT: 22.00 [21.33-29.00]. 
*p=0.011, Mann-Whitney U-test.  
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Supplementary Figure 1 
A: AAV2/5-EF1α-DIO-eYFP was 
injected into the MRR of vGluT2-Cre 
mice (n=2). 
B: Representative images from LHb 
(upper panel) and VDB (lower panel) 
show that eYFP-labelled MRR fibers 
(green) are indeed immunopositive 
for vGluT2 (red). Double 
immunopositive terminals are 
labelled with white arrowheads. At 
least 93% (339/367) of LHb and at 
least 97% (284/293) of VDB eYFP-
labelled MRR terminals were clearly 
immunopositive for vGluT2. Scale 
bar for both panels: 10 μm. 
C: Upper panel: representative 
images show that eYFP-labelled MRR 
terminals (green, white arrowheads) 
in the LHb are negative for SERT 
(red).  
Lower panel: representative images 
show that eYFP-labelled MRR 
terminals in the LHb (green, white 
arrowheads) are negative for vGluT3 
(red) or vGAT (white). In the LHb, 
only 4% (8/200) of eYFP-labelled 
terminals seemed positive for either 
vGluT3 or vGAT. In the VDB, only 8% 
(17/200) of eYFP-labelled MRR 
terminals seemed positive for either 
vGluT3 or vGAT. These few positive 
looking terminals were probably 
false positive due to detection 
issues. Scale bar for both panels: 10 
μm. 
D: Left panel: confocal fluorescent 
images show that eYFP-labelled MRR 
fibers (green) establish synaptic 
contacts (white arrowheads), 
marked by Homer-1 (white), with 
TpH positive (serotonergic) cells 
(red) in the MRR. Our measurements 
showed that at least 17% (113/680) 
of eYFP-labeled terminals 
established synaptic contacts on 
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TpH-positive profiles, and at least 68% (90/132) of TpH-positive cells received at least one synaptic contact 
from eYFP-labelled terminals (white arrowheads). 
Right panel: confocal fluorescent images show that eYFP-labelled MRR fibers (green) establish synaptic 
contacts (white arrowheads), marked by Homer-1 (white), with vGluT3-positive cells (red) in the MRR. Our 
measurements showed that at least 17% (132/797) of eYFP-labeled terminals established synaptic contacts on 
vGluT3-positive profiles, and at least 36% (48/135) of vGluT3-positive cells received at least one synaptic 
contact from eYFP-labelled terminals (white arrowheads). Scale bar for both panels: 10 μm. 
E: Anterograde tracer AAV2/5-EF1α-DIO-eYFP was injected into the MRR, and retrograde tracer CTB into the 
medial prefrontal cortex (PFC) of vGluT2-Cre mice (n=2). 
F: Fluorescent images show representative injection sites in the MRR and mPFC, respectively. Scale bars: 200 
μm. 
G: Confocal laser-scanning microscopy images show a medial VTA dopaminergic neuron (blue), retrogradely 
labeled with CTB (red) from the mPFC, receiving several Homer-1 (white) positive synaptic contacts from eYFP-
containing vGluT2-positive MRR fibers (green). Scale bar: 10 μm. 
H: Anterograde tracer AAV2/5-EF1α-DIO-mCherry and retrograde tracer CTB (diluted 1:1) was injected into the 
MRR and retrograde tracer FluoroGold (FG) was injected into the VTA of vGluT2-Cre mice (n=2). 
I: Fluorescent images show representative injection sites in the MRR and VTA, respectively.  
Scale bars: 200 μm. 
J: mCherry-containing vGluT2-positive MRR fibers (red) establish putative contacts with FG-positive (green) 
VTA projecting neurons (green arrows), with CTB-positive (blue) MRR projecting neurons (white arrows) and 
with FG-CTB-positive double projecting neurons (yellow arrows) in the LHb, respectively. Altogether, we 
counted 466 cells in the LHb that projected to the VTA and/or to the MRR, 70% (325/466) of which projected 
only to the VTA, 17% (78/466) only to the MRR and 13% (63/466) was double-projecting cells. 45% (63/141) of 
the cells that projected to the MRR, also projected to the VTA. Furthermore, 78% (254/325) of the cells 
projecting only to the VTA, 69% (54/78) of the cells projecting only to MRR and 78% (49/63) of the double-
projecting cells received at least 5 appositions from mCherry-containing MRR terminals. These data show that 
MRR vGluT2-neurons target LHb neurons, irrespectively from their preferences of targeting MRR or VTA.  Scale 
bar: 20 μm. 
K: Representative confocal fluorescent microscopic images show that only PV-positive, but not ChAT, vGluT2, 
calretinin (CR) or calbindin (CB)-positive MS/VDB cells received dense basket-like innervation from vGluT2-
positive MRR cells. Scale bar: 10 µm.   
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Supplementary Figure 2 
          
A: The anterograde tracer AAV2/5-EF1α-
DIO-mCherry and the retrograde tracer 
CTB was injected into the bilateral LHb 
and anterograde tracer AAV2/5-EF1α-
DIO-eYFP was injected into the MRR of 
vGluT2-Cre mice (n=2). B: Fluorescent 
images showing representative injection 
sites in the LHb and MRR, respectively. 
Scale bar: 100 μm. C: Confocal laser 
scanning microscopic images show that 
LHb vGluT2-positive fibers (red) establish 
synaptic contacts, marked by Homer-1 
(white), on a CTB-positive (blue), LHb-
projecting vGluT2-positive MRR neuron 
(green). At least 53% (32/60) of LHb-
projecting vGluT2-positive MRR cells 
received altogether 122 Homer-1 
positive synaptic contacts from vGluT2-
positive LHb neurons. Scale bar: 10 μm. 
D: Anterograde tracer AAV2/5-EF1α-DIO-
mCherry and retrograde tracer CTB was 
injected into the MRR of vGluT2-Cre mice 
(n=2). E: Confocal laser scanning 
microscopic images show that MRR 
vGluT2-positive fibers (red) establish 
synaptic contacts, marked by the 
scaffolding protein Homer-1 (white), with 
CTB-positive MRR-projecting LHb 
neurons (blue). At least 58% (71/122) of 
MRR-projecting LHb cells received 
altogether 268 Homer-1 positive synaptic 
contacts from vGluT2-positive MRR cells. 
Scale bar: 10 μm. 
F: AAV2/5-EF1α-DIO-ChR2-eYFP was 
injected into the bilateral LHb of vGluT2-
Cre mice (n=2). G: Upper panel: vGluT2-positive LHb fibers (green) establish Homer-1 (white) positive synaptic 
contacts with TpH-positive neurons (red) in the MRR. Our measurements showed that at least 12% (35/306) 
of eYFP labeled LHb terminals established synapses on TpH-positive profiles, while at least 57% (29/51) of TpH-
positive cells received at least one synaptic contact from eYFP-labelled terminals (white arrowheads). Lower 
panel: vGluT2-positive LHb fibers (green) establish Homer-1 (white) positive synaptic contacts with vGluT3-
positive neurons (red) in the MRR. Our measurements showed that at least 5% (11/223) of eYFP labeled LHb 
terminals established synapses on vGluT3-positive profiles, while at least 28% (10/36) of vGluT3-positive cells 
received at least one synaptic contact from eYFP-labelled terminals (white arrowheads). Scale bar for both 
panels: 20 μm.  
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Supplementary Figure 3  
A-I: AAV2/5-EF1α-DIO-eYFP 
was injected into various 
adjacent areas in the brainstem 
in vGluT2-Cre mice to confirm 
that the pathway described 
here originates selectively from 
the MRR (A-F). Furthermore, 
AAV2/5-EF1α-DIO-eYFP was 
injected into the MRR of TpH-
Cre (labeling serotonergic cells), 
vGluT3-Cre (labeling vesicular 
glutamate transporter type 3 
positive glutamatergic cells) 
and vGAT-Cre mice (labeling 
GABAergic cells) to illustrate 
that the pathway described 
here originates selectively from 
vGluT2-positive neurons in 
MRR (G-I). The images illustrate 
representative coronal sections 
from the regions of different 
injection sites and from the LHb 
and MS-VDB. The centers of the 
injection sites were also 
identified and defined by their 
anteroposterior coordinates 
from Bregma, as seen in the 
images. In LHb and MS/VDB, 
vGluT2-positive fibers can only 
be observed if viruses were 
injected into MRR (A), and they 
are absent in experiments, 
where the AAV-eYFP was 
injected into the neighboring 
brain areas (B-F) or into the 
MRR of TpH-Cre or vGluT3-Cre 
or GAT-Cre mice (G-I). All 
combinations of tracings were 
confirmed in at least 2 mice. 
Scale bars in panel I are 500 μm 
for all image columns. [Median 
raphe region (MRR), nucleus 
pontis oralis (PNO), dorsal 
raphe (DR), nucleus incertus (NI), mesencephalic reticular formation (mRT), pontine peduncular tegmentum 
(PPTg)]  
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Supplementary Figure 4 
 
A-B: Additional data for Fig. 3A. Population data for 10-90% rise and decay time distributions respectively in 
ms are as follows (median [25%-75% quartiles]), 10-90% rise time: 0.77 [0.66-1.14]; 10-90% decay time 5.06 
[4.10-7.03]. Original and averaged individual traces are also shown. 
C-F: Additional data for Fig. 6A-C. The number of aggressive events in the social interaction and resident-
intruder tests for CTRL- and h3MDq-mice, respectively are as follows (median [25%-75% quartiles]), social 
interaction test: CTRL: 0.00 [0.00-0.00]; h3MDq: 9.00 [2.00-9.00]; resident intruder test: CTRL: 0.00 [0.00-0.00]; 
h3MDq: 13.00 [2.00-20.00]. *: p=0.031, **: p=0.002, Mann-Whitney U-test. 
G-H: Additional data for Fig. 4A. Air puff-triggered change of firing was significantly correlated with the effect 
of LED flashes on the activity of the vGLuT2-positive MRR neurons (r=0.73, p=8*10-8).  
I: Population data for the number of total entries in the exploration of a Y-maze for CTRL- and h3MDq-mice 
are as follows (median [25%-75% quartiles]), CTRL: 33 [32-37]; h3MDq: 47 [41-56].  
***: p=4.71x10-4, Mann-Whitney U-test. 
J: Population data for the relative weight of adrenal glands to the body weight for CTRL- and h3MDq-mice, 
respectively are as follows, in mg/kg (mean +/- SD), CTRL: 180.661 +/- 34.88; h3MDq: 233.41 +/- 61.37. *: 
p=0.047, Student’s t-test.  
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Supplementary Figure 5  
 
 
Summary of virus injection sites in every mouse used in the behavioral opto- and chemogenetic experiments. 
The virus injection sites in the different mice participating in the different experiments were checked one-by-
one and overlaid onto each other in these images. AAV2/5-EF1a-DIO-ChR2-eYFP (ChR2) or AAV2/5-CAG-FLEX-
ArchT-GFP (ArchT) expression is labeled with green, AAV2/5-EF1a-DIO-eYFP (CTRL) expression is labeled with 
yellow, AAV2/8-hSyn-DIO-hM3Dq-mCherry is labeled with red and AAV2/8-hSyn-DIO-mCherry is labeled with 
orange in the area of MRR and adjacent structures at 3 different coronal levels (Bregma -4.35, -4.50 and -4.60 
mm, respectively). The tips of the optic fibers positioned over the MRR are also labeled as follows: In 
experiments comparing ChR2 stimulation vs. CTRL in the MRR (described in Fig.  5A-D), blue rhombs show the 
tip of optic fibers in ChR2-expressing mice, whereas blue circles show the tip of optic fibers in CTRL-mice. In 
experiments comparing ArchT inhibition vs. CTRL (described in Fig.  8E), orange rhombs show the tip of optic 
fibers in ArchT-expressing mice, whereas orange circles show the tip of optic fibers in CTRL-mice.  
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Supplementary Figure 6 
 
 
A: Animal movement traces of a representative CTRL- and ChR2-mouse during the habituation, real time place 
aversion (RTPA) and conditioned place aversion (CPA) experiments. Mice were light stimulated in the blue 
shaded area of the test chamber. The CTRL-mouse spent equal time in the two sides of the chamber, whereas 
the ChR2-mouse avoided the stimulation area during and 24 hours after the 25 Hz blue laser light stimulation 
of the vGluT2-positive MRR cells. We found no statistical difference either in the velocity of locomotion (Mann-
Whitney U-test, p=0.1293) or in distance travelled (Mann-Whitney U-test, p=0.1363) during RTPA experiments.  
B: Population data for the time spent in the two areas during habituation, RTPA and CPA tests (the latter two 
graphs are the same as in Fig. 5B). Medians and interquartile range shown on the graphs. (For statistical details 
see Suppl. Data for Fig. 5). 
C: Additional data for Fig. 5. Experimental design of optogenetic stimulation of vGluT2-positive MRR cells. 
During the 3 days following operant conditioning, animals gained back their original body weight. Mice were 
then placed into a new “opto-CFC” environment, and after 3 min of baseline freezing recording, they were 
light-stimulated for 10 times 15 seconds, with 15 seconds interstimulus interval. 24 hours later mice were 
placed back into the same environment to detect freezing levels. Freezing behavior was absent in both groups 
(n=7 CTRL and n=6 ChR2-mice) during both conditions. 
D: Additional data for Fig. 8E. Population data for the post-cue freezing levels (% of total time) in environment 
“B” for 13 CTRL- and 9 ArchT-mice are as follows: (median [25%-75% quartiles]), CTRL: 32.00 [15.67-42.67]; 
ArchT: 0.00 [0.00-14.33]. *p=0.021, Mann-Whitney U-test.  
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Supplementary Figure 7 
 
 
 
MRR vGluT2-neurons provide a neural hub for processing negative experiences.  
Illustration of the input and output connections of the MRR vGluT2-neurons (VG2). MRR vGluT2-neurons 
receive extensive inputs both from aversion-, freezing-, fear-related brain areas (see on the left) and from 
areas related to the memorization of negative experience (see on the left). In addition, MRR vGluT2-neurons 
project to LHb and mVTA, which are centers for aversion and for the prediction of negative experience, 
whereas they also project to the MS/VDB that induces hippocampal theta-rhythm activity, which is essential 
for contextual memory formation of negative experience. PAG: periaqueductal gray, ZI: zona incerta, LDTg: 
laterodorsal tegmental nucleus, LH: lateral hypothalamus, LPO/VP: lateral preoptic area & ventral pallidum, 
DR: dorsal raphe, Mam: mammillary complex, NI: nucleus incertus, MRR: median raphe region, VG2: vesicular 
glutamate transporter 2-positive neurons, VG3: vesicular glutamate transporter 3-positive neurons, 5TH: 
serotonergic neurons, LHb: lateral habenula, mVTA: medial ventral tegmental nucleus, DA: dopaminergic 
neurons, PFC: prefrontal cortex, MS/VDB: medial septum & vertical limb of the diagonal band of Broca, PV: 
parvalbumin-positive neurons, HIPP: hippocampus, IN: interneurons, PC: pyramidal cells.  
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Table S1: Characterization of used primary antibodies and retrograde tracers 
 
Antigen or 
reagent H
o
st
 
D
ilu
ti
o
n
 
Source 
C
at
al
o
g 
n
u
m
b
e
r 
Charac-
terization 
Specificity 
Calbindin 
R
ab
b
it
 
1
:2
0
0
0
 Kind gift 
from K. 
Baimbridg
e 
- 1 
The antibody recognizes one major 
broad band of the expected 
molecular weight (28 kDa) on 
western blots from rat cerebellum 
samples and immunostaining was 
abolished by preadsorption with 
the immunogen 
Calretinin 
M
o
u
se
 
1
:3
0
0
0
 
Swant  6
B
3
 
17 KO verified 
Choline 
Acetyltransferas
e (ChAT) M
o
u
se
 
1
:3
0
0
 Kind gift 
from C. 
Cozzari 
- 2,3 
Staining is typical for cholinergic 
cells; complete overlap of staining 
with eYFP-positive cells in ChAT-
iRES-Cre mice injected with AAV-
EF1a-DIO-eYFP 
Choleratoxin B 
subunit G
o
at
 
1
:2
0
0
0
0
 
List 
Biologicals #7
0
3
 
4 No staining in non-injected animals 
Choleratoxin B 
subunit M
o
u
se
 
1
:2
0
0
0
 
Abcam 
ab
1
0
0
3
 
5 No staining in non-injected animals 
Choleratoxin B 
subunit M
o
u
se
 
1
:5
0
0
 
Abcam 
ab
3
5
9
8
8
 
6 No staining in non-injected animals 
eGFP 
C
h
ic
ke
n
 
1
:2
0
0
0
 
Thermo 
Fisher 
Scientific A
1
0
2
6
2
 
17 
No staining in animals not injected 
with eGFP-expressing virus 
eGFP 
R
ab
b
it
 
1
:1
0
0
0
 
Thermo 
Fisher 
Scientific A
1
1
1
2
2
 
17 
No staining in animals not injected 
with eGFP-expressing virus 
Fluoro 
Gold R
ab
b
it
 
1
:5
0
0
 
Chemicon 
A
B
1
5
3
-i
 
7 No staining in non-injected animals 
Fluoro 
Gold 
G
u
in
ea
 p
ig
 
1
:5
0
0
0
 
Protos 
Biotech 
Corp N
M
-1
0
1
 
17 No staining in non-injected animals 
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Homer-1 
R
ab
b
it
 
1
:2
0
0
0
 
Synaptic 
Systems 
1
6
0
 0
0
3
 
17 
Specific for Homer 1. Cross-
reactivity of the serum to Homer 2 
and 3 was removed by pre-
adsorption with Homer 2 (aa 
1 - 176) and Homer 3 (aa 1 - 177). 
mCherry 
R
ab
b
it
 
1
:2
0
0
0
 
BioVision 
5
9
9
3
-1
0
0
 
17 
No staining in animals not injected 
with mCherry-expressing virus 
NMDA receptor 
GluN1 subunit R
ab
b
it
 
1
:2
0
0
 Kind gift 
from 
Watanabe 
M. 
- 8 KO verified 
NMDA receptor 
GluN2A subunit R
ab
b
it
 
1
:2
0
0
 Kind gift 
from 
Watanabe 
M. 
- 8 KO verified 
Parvalbumin 
G
u
in
ea
 p
ig
 
1
:1
0
0
0
0
 
Synaptic 
Systems 
1
9
5
 0
0
4
 
17, 9 
Labels the same cell populations in 
the brain as other antibodies to 
parvalbumin  
Parvalbumin 
R
ab
b
it
 
1
:2
0
0
0
 Kind gift 
from K. 
Baimbridg
e 
- 10, 11 
Labels the same cell populations in 
the brain as other antibodies to 
parvalbumin 
Parvalbumin  
M
o
u
se
 
1
:2
0
0
0
 
Swant  2
3
5
 
17 KO verified 
RFP 
R
ab
b
it
 
1
:4
0
0
0
 Rockland 
Immuno- 
chemicals 
Inc. 6
0
0
-4
0
1
-
3
7
9
 
17 
No staining in animals not injected 
with mCherry-expressing virus 
RFP R
at
 
1
:2
0
0
0
-
1
:5
0
0
0
 
Chromotek 5
F8
 
17 
No staining in animals not injected 
with mCherry-expressing virus 
SERT 
G
u
in
ea
 p
ig
 
1
:1
0
0
0
 
Frontier 
Institute 
2
5
7
1
7
7
7
 
12 
Immunoblot detects a single 
protein band at 67-69 kDa. This 
selectively stains serotonergic 
neurons and fibers. 
TH 
M
o
u
se
 
1
:2
0
0
0
 
Immuno 
Star 2
2
9
4
1
 
13 
Staining is typical for TH-positive 
cells 
TpH 
M
o
u
se
 
1
:3
0
0
0
 
Sigma-
Aldrich T0
6
7
8
 
17, 14 
Staining is typical for TpH-positive 
cells 
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vesicular GABA 
transporter 
(vGAT) 
G
u
in
ea
 p
ig
 
1
:2
0
0
0
 
Synaptic 
Systems 
1
3
1
 0
0
4
 
17 KO verified 
vesicular 
glutamate 
transporter, type 
2 (vGluT2) G
u
in
ea
 p
ig
 
1
:2
0
0
0
 
Synaptic 
Systems 
1
3
5
 4
0
4
 
17, 15 
The antibody recognizes one major 
broad band of the expected 
molecular weight (65 kDa) on 
western blots of a synaptic vesicle 
fraction of rat brain and 
immunostaining was abolished by 
preadsorption with the 
immunogen 
vesicular 
glutamate 
transporter, type 
3 (vGluT3) 
R
ab
b
it
 
1
:3
0
0
 
Synaptic 
Systems 
1
3
5
 2
0
3
 
17 KO verified 
vesicular 
glutamate 
transporter, type 
3 (vGluT3) G
u
in
ea
 p
ig
 
1
:5
0
0
-
1
:1
0
0
0
 
Frontier 
Institute 
5
2
2
 5
8
8
 
17 
Immunoblot detects a single 
protein band at 60-62 kDa. This 
stains distinct neuronal 
populations, which have not been 
classified as glutamatergic neurons.  
DAPI  
1
:1
0
0
0
0
 
Sigma-
Aldrich 
 - nuclear marker 
Choleratoxin B 
subunit 
 
0
,5
%
 
List 
Biologicals  #1
0
4
 
16 retrograde tracer 
FluoroGold  2
%
 Fluoro 
Chrome 
Inc. 
- 16 retrograde tracer 
References: 1. Buchan, A. M. et al., Peptides 9, 333–8; 2. Chédotal, A. et al., Brain Res. (1994); 3. Takács, V. 
T. et al., Nat. Commun. 9, 2848 (2018); 4. Dederen, P. J. et al., Histochem. J. 26, 856–62 (1994); 5. 
Hamorsky, K. T. et al., PLoS Negl. Trop. Dis. (2013); 6. Dautan, D. et al., Nat. Neurosci. (2016). 7. Varga, C. et 
al., J. Neurosci. 22, 6186–94 (2002). 8. Watanabe, M. et al. Eur. J. Neurosci. 10, 478–87 (1998), 9. Hartwich, 
K. et al., J. Neurosci. (2012). 10. Mascagni, F. et al., Neuroscience 158, 1541–50 (2009), 11. Condé, F. et al., 
J. Comp. Neurol. 341, 95–116 (1994), 12. Somogyi, J. et al., Eur. J. Neurosci. 19, 552–69 (2004), 13. 
Chermenina, M. et al., Parkinsons. Dis. (2015), 14. Kodani, S. et al., J. Neurosci. 37, 7164–7176 (2017). 15. 
Broms, J. et al., J. Comp. Neurol. (2015), 16. Lanciego, J. L. et al., Journal of Chemical Neuroanatomy 
(2011). 17. Information is provided by the distributor.  
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Table S2: Secondary antibodies 
 
Raised in 
Raised 
against 
Conjugated with Dilution Source 
Catalog 
number 
Donkey Rabbit Alexa 647 1:500 Jackson Immunoresearch 711-605-152 
Donkey Mouse Alexa 647 1:500 Jackson Immunoresearch 715-605-151 
Donkey Guinea pig Alexa 647 1:500 Jackson Immunoresearch 706-605-148 
Goat Chicken Alexa 488 1:1000 ThermoFisher Scientific A11039 
Donkey Rabbit Alexa 488 1:1000 ThermoFisher Scientific A21206 
Donkey Mouse Alexa 488 1:500 ThermoFisher Scientific A21202 
Goat Guinea pig Alexa 488 1:500 ThermoFisher Scientific A11073 
Donkey Rabbit Alexa 594 1:500 ThermoFisher Scientific A21207 
Donkey Rat Alexa 594 1:500 ThermoFisher Scientific A21209 
Donkey Guinea pig Alexa 594 1:500 Jackson Immunoresearch 706-585-148 
Donkey Mouse Alexa 594 1:500 ThermoFisher Scientific A21203 
- - DyLight405 1:500 Jackson Immunoresearch 016-470-084 
Goat Rabbit 1.4 nm gold 1:100 Nanoprobes #2004 
Goat Chicken biotinylated 1:200 Vector Laboratories BA-9010 
Donkey Mouse biotinylated 1:1000 Jackson Immunoresearch 715-066-151 
Goat Rabbit biotinylated 1:1000 Rocklan Immunochemicals Inc. 611-106-B76 
Horse Mouse 
Horseradish 
peroxidase 
(ImmPress) 
1:3 Vector Laboratories MP-7402 
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Table S3: Primary and secondary antibody combinations used in immunofluorescent experiments 
 
mouse 
strain 
experiment 
types 
used primary 
antibodies or 
reagents 
used secondary antibodies note 
vGluT2-
Cre 
Stereology 
DAPI  - 
Stereological measurement 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
rabbit-anti-
vGluT3 
Alexa 594-conjugated 
donkey-anti-rabbit 
mouse-anti-TpH 
Alexa 647 conjugated 
donkey-anti-mouse 
vGluT2-
Cre 
viral 
anterograde 
tracing 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling the injection sites 
and ascending fibers from 
MRR in vGluT2-Cre mice 
vGluT2-
Cre 
viral 
anterograde 
tracing, 
monosynaptic 
rabies tracing 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling the injection sites 
and ascending fibers from 
DR, NI, mRT, PnO, PPTg in 
vGluT2-Cre mice. 
 Injection site analysis and 
identification of 
monosynaptically labeled 
cells in the forebrain and in 
the brainstem 
rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
vGAT-Cre, 
vGluT3-
Cre, TpH-
Cre 
viral 
anterograde 
tract-tracing 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling the injection sites 
and ascending fibers from 
MRR in vGAT-Cre, vGluT3-
Cre, TpH-Cre mouse 
vGluT2-
Cre 
Analysis of the 
neurochemical 
identity of 
MRR fibers 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
 vGluT2-labeling and MRR 
fibers identification in the 
forebrain 
guinea pig anti-
vGluT2 
Alexa 594-conjugated 
donkey-anti-guinea pig 
vGluT2-
Cre 
Analysis of the 
neurochemical 
identity of 
MRR fibers 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
 vGluT3 and vGAT-labeling 
and MRR fibers identification 
in the forebrain 
rabbit anti-
vGluT3 
Alexa 594-conjugated 
donkey-anti-rabbit 
guinea pig anti-
VGAT 
Alexa 647 conjugated 
donkey-anti-guinea pig 
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vGluT2-
Cre 
Analysis of the 
neurochemical 
identity of 
MRR fibers 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken SERT-labeling and MRR fibers 
identification in the forebrain guinea pig anti-
SERT 
Alexa 594-conjugated 
donkey-anti-guinea pig 
vGluT2-
Cre 
Target cell 
selectivity of 
LHb fibers in 
the MRR; Local 
connections of 
MRR vGluT2 
fibers to 
vGluT3+ cells 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling vGluT3 cells in the 
MRR 
guinea pig-anti-
vGluT3 
Alexa 594-conjugated 
donkey-anti-guinea pig 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
Target cell 
selectivity of 
LHb fibers in 
the MRR; Local 
connections of 
MRR vGluT2 
fibers to 
serotonergic 
cells 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling serotonergic cells in 
the MRR 
mouse-anti-TpH 
Alexa 594 conjugated 
donkey-anti-mouse 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the LHb and 
LHb fibers in 
the MRR 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Viraly labeling vGluT2 cells in 
LHb and MRR 
rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
Target cell 
selectivity of 
LHb fibers in 
MRR  
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Measurement from 
retrogradely traced vGluT2-
positive cells from LHb in the 
MRR  
rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
mouse-anti-
Choleratoxin B 
biotinylated donkey-anti-
mouse + DyLight405 
conjugated streptavidin 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the LHb  
guinea pig-anti-
FluoroGold 
Alexa 488-conjugated goat-
anti-guinea pig 
Retrograde tracing from VTA 
and MRR in the LHb 
rabbit-anti-
mCherry 
Alexa 594-conjugated 
donkey-anti-rabbit 
mouse-anti-
Choleratoxin B 
Alexa 647-conjugated 
donkey-anti-mouse 
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vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the LHb  
mouse-anti-
Choleratoxin B 
Alexa 488-conjugated 
donkey-anti-mouse 
Measurement from 
retrograde tracing from MRR 
in the LHb  
rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the mVTA 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
LHb and MRR vGluT2-
neurons target medial VTA 
DA neurons  
rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
mouse-anti-TH 
biotinylated donkey-anti-
mouse + DyLight405 
conjugated streptavidin 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the mVTA 
chicken-anti-
eGFP 
Alexa 488-conjugated 
donkey-anti-chicken 
MRR vGluT2-neurons target 
medial VTA DA neurons that 
project to PFC 
goat-anti-CTB 
Alexa 594-conjugated 
donkey-anti-goat 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
mouse-anti-TH 
biotinylated donkey-anti-
mouse + DyLight405 
conjugated streptavidin 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the VDB 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling PV positive cells in 
the VDB 
mouse-anti-
Parvalbumin 
Alexa 594 conjugated 
donkey-anti-mouse 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the VDB 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling PV and ChAT 
positive cells in the VDB 
rabbit-anti-
Parvalbumin 
Alexa 594 conjugated 
donkey-anti-rabbit 
mouse-anti-
ChAT 
Alexa 647 conjugated 
donkey-anti-mouse 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the VDB 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken Labeling CR positive cells in 
the VDB mouse-anti-
Calretinin 
Alexa 647 conjugated 
donkey-anti-mouse 
vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the VDB 
chicken-anti-
eGFP 
Alexa 488-conjugated goat-
anti-chicken 
Labeling vGluT2+ and CB 
positive cells in the VDB rat-anti-RFP 
Alexa 594-conjugated 
donkey-anti-rat 
rabbit-anti-
calbindin 
Alexa 647-conjugated 
donkey-anti-rabbit 
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vGluT2-
Cre 
Target cell 
selectivity of 
MRR fibers in 
the LHb  
guinea pig-anti-
FluoroGold 
Alexa 488-conjugated goat-
anti-guinea pig 
Measurement from 
retrograde tracing from HIPP 
in the VDB 
rabbit-anti-
mCherry 
Alexa 594-conjugated 
donkey-anti-rabbit 
mouse-anti-
Parvalbumin 
Alexa 647-conjugated 
donkey-anti-mouse 
vGluT2-
Cre 
Post-hoc 
anatomical 
identification 
of in vitro 
labeled cells in 
the LHb 
chicken-anti-
eGFP 
Alexa 488-conjugated 
donkey-anti-rabbit 
Labeling of MRR fibers and in 
vitro labeled cells in LHb 
Alexa 594-
conjugated 
Streptavidin 
Alexa 594-conjugated 
Streptavidin 
rabbit-anti-
Homer 
Alexa 647-conjugated 
donkey-anti-rabbit 
vGluT2-
Cre 
VDB-LHb 
double 
retrograde 
tracing 
rabbit-anti-
FluoroGold 
Alexa 488-conjugated 
donkey-anti-rabbit 
Identification of the 
retrogradely labeled cells in 
the MRR 
rat-anti-RFP Alexa 594-conjugated 
donkey-anti-rat 
mouse-anti-
Choleratoxin B 
Alexa 647-conjugated 
donkey-anti-mouse 
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Table S4: Primary and secondary antibody combinations used in immunoperoxidase and electron microscopic 
experiments 
 
vGluT2-Cre 
Analysis of NMDA 
receptor GluN2A subunit 
positivity of MRR fibers in 
the LHb and MS 
chicken-anti-eGFP 
biotinylated 
goat-anti-
chicken 
Correlated 
double 
immunogold-
immuno-
peroxidase 
electron 
microscopy for 
glutamatergic 
molecular 
machinery 
analysis in MRR 
vGluT2 fibers 
rabbit-anti-NMDA 
receptor NR2A 
subunit 
1.4 nm gold 
conjugated 
goat-anti-rabbit 
vGluT2-Cre 
Analysis of NMDA 
receptor GluN1 subunit 
positivity of MRR fibers in 
the LHb 
chicken-anti-eGFP 
biotinylated 
goat-anti-
chicken 
rabbit-anti-NMDA 
receptor NR1 subunit 
1.4 nm gold 
conjugated 
goat-anti-rabbit 
vGluT2-Cre 
Parvalbumin-specificity 
of MRR fibers in the VDB 
chicken-anti-eGFP 
biotinylated 
goat-anti-
chicken 
Correlated 
double SI-
DAB/DAB-Ni 
electron 
microscopy for 
target specificity 
of MRR fibers in 
the MS/VDB 
mouse-anti-
Parvalbumin 
ImmPress 
horse-anti-
mouse 
vGluT2-Cre Experiment for BFSEM rabbit-anti-eGFP 
1.4 nm gold 
conjugated 
goat-anti-rabbit 
MRR terminal 
reconstruction in 
LHb 
vGluT2-Cre 
Chemogenetic virus 
injection site 
identification 
rabbit-anti-RFP 
biotinylated 
goat-anti-rabbit 
Chemogenetic 
virus injection 
site identification 
 
  
51 
 
Table S5: Stereological estimation of MRR neurons 
 
  Mouse1 Mouse2 Mouse3 Average 
Total counted vGluT2 positive neurons 8524 7014 4826 6788 
Total counted TpH or/and vGluT3 positive neurons 5886 3362 3995 4414 
vGluT2 positive neurons / TpH and/or vGluT3 
positive neurons 1,45 2,09 1,21 1,58 
       
All TpH and/or vGluT3 positive neurons (22) 6067 
Total neurons (22) 47458 
vGluT2 positive neurons in MRR 1,58*6067 = 9586 
vGluT2 positive neurons ratios in MRR 20,20% 
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Table S6: Quantification of monosynaptically-labeled neurons with rabies virus in the different 
 brain areas projecting to MRR vGluT2 neurons. 
 
Brain area /Nucleus 
Median 
% 
Estimation of cell numbers 
per brain area 
Behavioral relevance Ref.  
    Mouse1 Mouse2 Mouse3     
Lateral habenular 
nucleus 
10,0% 588 456 756 aversion center, depression 1–4 
Mammillary region 8,5% 504 396 252 memory formation 5,6 
Dorsal raphe nucleus 7,8% 468 354 678 
Anti-aversion, 
antidepressant  
7,8 
VTA together 7,4% 438 384 384 aversion, reward 9 
Lateral hypothalamic 
area 
6,6% 408 300 510 cued-dependent aversion 10,11 
PAG together 6,0% 354 342 324 freezing behavior 12 
Laterodorsal tegmental 
nucleus 
5,9% 348 174 721 
innate fear, reward 
processing 
13,14 
Nucleus pontis oralis 5,2% 198 234 846 REM sleep, theta generation 15 
Zona incerta 4,0% 258 24 360 fear, freezing, attention 16–18 
PFC together 2,3% 138 108 78 fear, reward, aversion 14,19 
Nucleus incertus 1,7% 300 78 126 memory formation 20 
Raphe magnus nucleus 1,6% 108 42 144 pain inhibition 21 
Lateral preoptic area 1,5% 90 144 78 aversion, reward 22 
Ventral pallidum 1,3% 102 60 84 reward seeking 23 
Posterior hypothalamic 
nucleus 
1,2% 72 42 192 
theta rhythm, spatial 
memory 
24,25 
Dorsomedial 
hypothalamic nucleus 
1,1% 6 66 96 circadian rhythms 26 
Substantia nigra, 
reticular part 
1,1% 66 12 156 motor control 27,28 
Rostral linear nucleus 1,0% 60 78 0 olfactory-guided behavior 29 
TOTAL 74,43% 4506 3294 5785     
References: 1. Stephenson-Jones et al., Proc. Natl. Acad. Sci. 109, E164–E173 (2012), 2. Stopper et al., Nat. 
Neurosci. 17, 33–35 (2014), 3. Li et al., Elife 8, 1–17 (2019). 4. Yang, Y. et al., Nature 554, 317–322 (2018), 5. 
Dillingham et al., Neurosci. Biobehav. Rev. 54, 108–119 (2015), 6. Vann, S. D. et al., Nat. Rev. Neurosci. 5, 35–
44 (2004). 7. Luo, M. et al., Learn. Mem. 22, 452–460 (2015), 8. Zhang, H. et al., Brain Struct. Funct. 223, 
2243–2258 (2018), 9. Lammel, S. et al., Neuropharmacology 76 Pt B, 351–9 (2014), 10. de Jong, J. W. et al., 
Neuron (2019), 11. Lazaridis, I. et al., Mol. Psychiatry (2019), 12. Tovote, P. et al. Nature 534, 206–212 (2016), 
13. Yang, H. et al., Nat. Neurosci. 19, 283–9 (2016), 14. Lammel, S. et al., Nature 491, 212–217 (2012), 15. 
Sanford, L. D. et al., J. Neurophysiol. 90, 938–945 (2006). 16. Chou, X. L. et al. Nat. Commun. 9, 1–12 (2018), 
17. Watson et al., J. Neurosci. 35, 9463–9476 (2015), 18. Chometton, S. et al., Brain Struct. Funct. (2017), 19. 
Rozeske et al., Genes, Brain Behav. 14, 22–36 (2015), 20. Szőnyi, A. et al., Science 364, (2019), 21. Brodie et 
al., Brain Res. (1986), 22. Barker, D. J. et al., Cell Rep. 21, 1757–1769 (2017), 23. Tooley, J. et al., Biol. 
Psychiatry (2018), 24. Bocian, R. et al., Hippocampus 26, 1354–1369 (2016), 25. Gutiérrez-Guzmán, B. E. et 
al., Eur. J. Pharmacol. 682, 99–109 (2012), 26. Chou, T. C. et al., J. Neurosci. (2003), 27. Hikosaka, O. et al., J. 
Neurophysiol. (1983), 28. Sato, M. et al., J. Neurosci. (2002), 29. Del-Fava, F. et al., Neuroscience (2007). 
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